cephalosporin c has been researched along with Cross Infection in 631 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 110 (17.43) | 18.7374 |
1990's | 126 (19.97) | 18.2507 |
2000's | 172 (27.26) | 29.6817 |
2010's | 187 (29.64) | 24.3611 |
2020's | 36 (5.71) | 2.80 |
Authors | Studies |
---|---|
Bosheva, M; Cossey, V; Gardovska, D; Hamed, K; Hornik, CD; Kwinta, P; Litherland, K; Liubsys, A; Münch, HG; Polak, M; Rubino, CM; Ruehle, C; Schröpf, S; Smits, A; Snariene, R; Tomasik, T | 1 |
Adalia, R; Aguilar, G; Azanza, JR; Barberán, J; Borges, M; Bou Arévalo, G; Cardinal-Fernández, P; Estella, A; Fernández Gómez, J; Ferrer, R; González de Molina, FJ; León López, R; LLinares Mondéjar, P; Marco, F; Maseda, E; Mensa, J; Oliver, A; Pasquau, J; Poliakova, Y; Rascado, P; Robles Marcos, MS; Salavert, M; Serrano García, R; Soriano, A | 1 |
Pitout, JDD | 1 |
Echols, R; Matsunaga, Y; Menon, A; Portsmouth, S; Skaar, EP | 1 |
Bakhtiar, A; Chong, CW; Khalid, KE; Khan, RA; Tan, SY | 1 |
Candel, FJ; González Del Castillo, J; Julián Jiménez, A; Matesanz, M | 1 |
Badoordeen, GZ; Blakeway, LV; Byers, SMH; Cheng, AC; Cooper, BS; Cottingham, H; Hawkey, J; Jenney, AWJ; Lee, SJ; Loftus, MJ; Macesic, N; Naidu, R; Peleg, AY; Prasad, A; Prasad, V; Rafai, E; Stewardson, AJ; Tudravu, L; Vakatawa, T; van Gorp, E; Wati, S; Wisniewski, JA; Young-Sharma, TEMW | 1 |
Guo, RS; Hu, NY; Liang, W; Wan, LJ; Xie, BL; Xu, JQ; Yang, XW; Yao, WY; Yi, Z; Zhang, B | 1 |
Hrynchuk, OB; Ishchak, OM; Kolesnik, AV; Rud, VO; Salmanov, AG; Terekhov, VA; Voloshynovych, NS | 1 |
Baier, C; Bange, FC; Böhne, C; Bohnhorst, B; Ebadi, E; Hansen, G; Knegendorf, L; Peter, C; Pirr, S; Schlüter, D; Schwab, F; Vital, M | 1 |
Asch, J; Coombs, J; Fernley, T; Ford, CD; Hoda, D; Hunter, BD; Lopansri, BK | 1 |
Gan, DK; Lin, X; Wu, W; Xiong, ML; Zhou, W; Zhu, LC; Zou, B | 1 |
Bartoletti, M; Bassetti, M; Bavaro, DF; Bono, VD; Buonomo, AR; Canta, F; Carbonara, S; Congera, P; Corcione, S; De Rosa, FG; Durante-Mangoni, E; Falcone, M; Gentile, I; Giacobbe, DR; Karruli, A; Maraolo, AE; Mikulska, MK; Moriello, NS; Palmiero, G; Paradiso, L; Sordella, F; Tascini, C; Tiseo, G; Vena, A; Viale, P; Vozza, A | 1 |
Han, X; Hu, H; Jiang, Y; Liao, W; Meng, Y; Quan, J; Shi, Q; Wang, Q; Yu, Y; Zhang, H; Zhao, D; Zhou, J | 1 |
Bonten, MJM; Brun-Buisson, C; Plantinga, NL; Wittekamp, BHJ | 1 |
Bou, G; Cabot, G; Cortes-Lara, S; Del Barrio-Tofiño, E; López-Causapé, C; Martínez-Martínez, L; Oliver, A; Sánchez-Diener, I; Zamorano, L | 1 |
Cotta, MO; Dulhunty, JM; Eriksson, L; Harris, P; Malacova, E; Milinovich, GJ; Vickers, ML | 1 |
Bonten, MJM; Bruijning-Verhagen, PC; de Smet, AMGA; de Wit, GA; Oostdijk, EAN; Plantinga, NL; van Hout, D; van Werkhoven, CH | 1 |
Cuesta, M; Gonzalez-Zorn, B; Hoefer, A; Ortega-Huedo, R | 1 |
Hung, YP; Ko, WC; Lee, JC; Lin, HJ; Liu, HC; Tsai, BY; Tsai, PJ; Wu, JL | 1 |
Higuita-Gutiérrez, LF; Jiménez-Quiceno, JN; Vargas-Alzate, CA | 1 |
Bruno, CJ; Butterton, JR; Huntington, JA; Kivistik, Ü; Kollef, MH; Lin, G; Martin-Loeches, I; Nováček, M; Réa-Neto, Á; Rhee, EG; Shime, N; Timsit, JF; Wunderink, RG; Yu, B | 1 |
Kalil, AC; Zavascki, AP | 1 |
Antonelli, A; Arena, F; Colavecchio, OL; Conte, V; Coppi, M; Di Pilato, V; Giani, T; Rossolini, GM; Santerre Henriksen, A | 1 |
Bardonneau, G; Biais, M; Carrié, C; Gruson, D; Ouattara, A; Pereira, B; Petit, L | 1 |
Bruno, CJ; Kollef, MH; Réa-Neto, Á; Rhee, EG; Wunderink, RG | 1 |
Lai, CC; Tang, HJ | 1 |
Bassetti, M; Cattelan, A; Giacobbe, DR; Mussini, C; Vena, A | 1 |
Begović-Kuprešanin, V; Dragojević-Simić, V; Jovanović, D; Milenković, B; Perić, A; Starčević, S; Šuljagić, V; Tomić, A; Vezmar Kovačević, S | 1 |
Karlowsky, JA; Kazmierczak, KM; Motyl, MR; Sahm, DF; Young, K | 1 |
Brown, SM; Ferraro, J; Goodman, B; Jones, PB; Lopansri, B; Stenehjem, E; Subramanian, A; Webb, BJ | 1 |
Gatermann, SG; Körber-Irrgang, B; Korte-Berwanger, M; Kresken, M; Pfennigwerth, N; Seifert, H | 1 |
Dumyati, GK; Fridkin, SK; Gerber, JS; Guh, AY; Hamilton, KW; Laguio-Vila, M; Lautenbach, E; Muller, BM; Reddy, SC; Shakamuri, NS; Szymczak, JE | 1 |
Bonten, MJM; Deelen, JWT; Giron Ortega, JA; Harbarth, S; Jacobsson, G; Rodriguez-Baño, J; Rottier, WC; Tacconelli, E; van Werkhoven, CH; Zahar, JR | 1 |
Carvalhaes, CG; Duncan, LR; Flamm, RK; Sader, HS; Shortridge, D | 1 |
Asensio-Martín, MJ; Balandin, B; Ballesteros, D; Chicot, M; Fernández-Simón, I; Iranzo, R; López-Vergara, L; Martínez-Sagasti, F; Pérez-Pedrero, MJ; Pintado, V; Rodríguez-Serrano, D; Royuela, A; Ruiz de Luna, R; Sancho-González, M; Silva, A; Soriano-Cuesta, C | 1 |
Bosheva, M; Gujabidze, R; Hamed, KA; Károly, É; Nemeth, A; Saulay, M; Smart, JI | 1 |
Bardonneau, G; Biais, M; Carrie, C; Oddos, C; Petit, L | 1 |
Hesketh, T; Kritsotakis, EI; Wang, J; Zhou, M | 1 |
Aronica, R; Cancelli, F; Mastroianni, CM; Mauro, V; Oliva, A; Romani, F; Savellon, G; Valeri, S | 1 |
Engelhardt, M; Gao, L; Hamed, K; Huang, H; Saulay, M | 1 |
Basumatary, MK; Bhattacharjee, A; Chakravarty, A; Choudhury, D; Dhar, D; Ingti, B; Maurya, AP; Mishra, S; Paul, D; Talukdar, AD | 1 |
Ajilda, AAK; Padmini, N; Selvakumar, G; Sivakumar, N | 1 |
Atkinson, A; Kronenberg, A; Lo Priore, EF; Marschall, J; Sommerstein, R | 1 |
Kim, HS; Kim, HY; Kim, YK; Lee, J; Lee, JA; Lee, SS; Seo, YB; Song, W; Uh, Y | 1 |
Hollenberg, SM; Khan, ZA | 1 |
Cheng, A; Chuang, YC; Sheng, WH; Wang, JT; Yang, JJ | 1 |
Grupper, M; Nicolau, DP; Sutherland, C | 1 |
Chmielarczyk, A; Krzyściak, P; Pobiega, M; Romaniszyn, D; Wójkowska-Mach, J | 1 |
Bonten, MJM; Bootsma, MCJ; Dautzenberg, MJD; Derde, LPG; Gniadkowski, M; Gurieva, T | 1 |
Gomez-Simmonds, A; McConville, TH; Sullivan, SB; Uhlemann, AC; Whittier, S | 1 |
Lodise, TP; Natesan, S; Pai, MP | 1 |
Delorme, T; Garcia, A; Nasr, P | 1 |
Arena, F; Bassetti, M; D'Andrea, MM; Di Pilato, V; Giani, T; Henrici De Angelis, L; Pollini, S; Rossolini, GM | 1 |
Adam, H; Baxter, M; Hoban, DJ; Karlowsky, JA; Lagacé-Wiens, P; Walkty, A; Zhanel, GG | 2 |
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Balamitsa, E; Bonsignore, M; Geffers, C; Nachtigall, I; Nobis, C; Tafelski, S | 1 |
Chen, B; Huang, H; Huang, X; Huang, Z; Lian, X; Liu, G; Ran, J; Wang, N | 1 |
Alfandari, S; Bertrand, X; Dumartin, C; Gauzit, R; Gbaguidi-Haore, H; Muller, A; Péfau, M; Rogues, AM | 1 |
Gastmeier, P; Kern, WV; Mischnik, A; Rohde, AM; Schwab, F; Seifert, H; Wiese-Posselt, M; Zweigner, J | 1 |
Branislava, K; Niko, R; Nikola, S; Predrag, S; Stanković-Đorđević, D; Zorica, SR | 1 |
Gandra, S; Laxminarayan, R; Logan, LK; Trett, A; Weinstein, RA | 1 |
Ammerlaan, HSM; Bamberg, YRP; Bonten, MJM; Dorigo-Zetsma, JW; Kluytmans, JAJW; Kuck, EM; Prins, JM; Rottier, WC; Thijsen, SFT; van de Garde, EM; van der Linden, PD; van Hees, BC; van Werkhoven, CH; Verbon, A; Vlaminckx, BJM | 1 |
Agoba, EE; Essack, SY; Govinden, U; Osei Sekyere, J; Peer, AKC | 1 |
Almuzara, M; Chiem, K; Collins, C; Iriarte, A; Montaña, S; Mussi, MA; Ramirez, MS; Saigo, M; Tolmasky, M; Traglia, G; Vay, C | 1 |
Finklea, JD; Hollaway, R; Jain, R; Le, J; Lee, F; Lowe, K | 1 |
Hao, D; Hu, Z; Liu, X; Sun, T; Tian, H; Wang, T; Wang, X | 1 |
Cronin, K; Engler, C; Norton, R; Parsonson, F; Slack, A | 1 |
Avendano, EE; Chan, J; Merchant, S; Puzniak, L; Raman, G | 1 |
Chen, Z; Kang, M; Li, M; Liu, M; Song, Q; Wu, L; Xie, Y; Zhao, D | 1 |
Balasubramanian, U; Bharadwaj, R; Gupta, A; Johnson, J; Kadam, D; Kagal, A; Kanade, S; Khadse, S; Kinikar, A; Kulkarni, V; Marbaniang, I; Mave, V; Nelson, G; Raichur, P; Robinson, ML; Sachs, J; Suryavanshi, N; Valvi, C; Zenilman, J | 1 |
Aliberti, S; Blasi, F; Di Pasquale, M; Gramegna, A; Mantero, M; Saderi, L; Sotgiu, G; Trogu, F | 1 |
Edman-Wallér, J; Jacobsson, G; Karp, J; Lundqvist, A; Toepfer, M | 1 |
Fernández Esgueva, M; Ferrer Cerón, I; García-Lechuz Moya, JM; López-Calleja, AI; Morilla Morales, E; Nuñez Medina, R; Rezusta López, A; Sahagún Pareja, J; Viñuelas Bayon, J | 1 |
Dhanda, RS; Gaind, R; Mittal, G; Nagarjuna, D; Yadav, M | 1 |
Antona, C; Bandi, C; Brilli, M; Comandatore, F; Dichirico, B; Gismondo, MR; Piazza, A; Ridolfo, A; Rimoldi, SG; Romeri, F | 1 |
Armean, S; Behnke, M; Feihl, S; Gastmeier, P; Gebhardt, F; Hamprecht, A; Ihle, V; Kern, WV; Knobloch, JK; Kola, A; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, AM; Schröder, W; Schwab, F; Seifert, H; Tacconelli, E; Vehreschild, MJGT; Wiese-Posselt, M; Zweigner, J | 1 |
Basak, GW; Saran, O; Sulik-Tyszka, B; Wróblewska, MM | 1 |
Dumic, I; Lalosevic, MS; Milovanovic, T; Nikolic, V; Palibrk, I; Veličkovic, J | 1 |
Alemkere, G; Engidawork, E; Tenna, A | 1 |
Engelhardt, M; Hamed, K; Santerre-Henriksen, A; Saulay, M; Scheeren, TWL; Welte, T | 1 |
Baggs, J; Guh, A; Hatfield, KM; Jernigan, JA; Kazakova, SV; McDonald, LC; Reddy, SC; Yi, SH | 1 |
DePestel, DD; DeRyke, CA; Gupta, V; Merchant, S; Murray, J; Puzniak, L; Srinivasan, A; Ye, G | 1 |
Abrar, S; Ain, NU; Hussain, S; Liaqat, H; Rasheed, F; Riaz, S | 1 |
Epson, E; Horwich-Scholefield, S; Rizzo, K | 1 |
Al Saif, S; Aljohany, SM; Alshaalan, M; AlShehri, A; Balkhy, HH; El-Metwally, A; El-Saed, A; Hijazi, O | 1 |
Agnelli, F; Baratta, F; Colombo, F; Frantellizzi, V; Pani, A; Pastori, D; Scaglione, F | 1 |
Hurley, JC | 1 |
Cillóniz, C; Dominedò, C; Garcia-Vidal, C; Torres, A | 1 |
Barberán, J | 1 |
Grau, S | 1 |
Boulanger, B; Cizeau, F; Decousser, JW; Ducellier, D; Fourreau, F; Mercier-Darty, M; Mongardon, N; Podglajen, I; Potron, A; Royer, G | 1 |
Mouton, JW; Muller, AE; Punt, N; Schmitt-Hoffmann, AH | 1 |
Chang, HL; Chang, HY; Chang, YF; Chi, CY; Ho, CM; Ho, MW; Lai, CH; Lin, CD; Lin, CW; Lin, HH; Lu, JJ; Teng, LJ; Tien, N; Tseng, SP | 1 |
Bellon, O; Boutet-Dubois, A; Bouziges, N; Brieu-Roche, N; Davin-Regli, A; Dunyach-Remy, C; Gleize, E; Lamarca, R; Lavigne, JP; Le Coustumier, A; Lecaillon, E; Pantel, A; Prère, MF; Sotto, A; Villeneuve, L | 1 |
Chen, JH; He, YQ; Liu, S; Wan, YF; Xu, CQ; Ye, ML; Zheng, YL; Zhou, LY | 1 |
Bateman, BT; Bykov, K; Choudhry, NK; Fischer, MA; Franklin, JM; Gagne, JJ; Kulik, A; Liu, J; Polinski, JM; Rassen, JA; Schneeweiss, S | 1 |
Lagacé-Wiens, PR; Rubinstein, E | 1 |
Alahmadi, YM; Aldeyab, MA; Conlon, G; Kearney, MP; Magee, FA; McElnay, JC; Scott, MG | 1 |
Edquist, P; Melhus, Å; Starlander, G; Yin, H | 1 |
Droz, S; Endimiani, A; Hilty, M; Kronenberg, A; Perreten, V; Seiffert, SN | 1 |
Chang, YM | 1 |
Adam, HJ; Baxter, MR; Hoban, DJ; Karlowsky, JA; Lagacé-Wiens, PR; Walkty, AJ; Zhanel, GG | 1 |
Carbonneau, M; Chang, HJ; Chaulk, J; Keough, A; Kumar, D; Ma, M; Qamar, H; Tandon, P | 1 |
Bai, C; Chen, Y; Li, D; Zhang, P; Zhang, Q; Zhang, W; Zheng, S | 1 |
Christiansen, KJ; Coombs, GW; Pearson, JC; Robinson, JO | 1 |
Ibrahim, SA; Noreddin, AM; Salem, AH; Zhanel, GG | 1 |
Chen, R; Chen, Y; Guo, L; Han, L; Han, X; Luo, Y; Tian, S; Yang, J; Ye, L; Zhao, J; Zhao, Q | 1 |
Muscedere, J | 1 |
File, TM; Pasquale, TR; Tan, MJ; Trienski, TL | 1 |
Livermore, DM | 1 |
Calbo, E; Zaragoza, R | 1 |
Awad, SS; Chuang, YC; Engelhardt, M; Marjanek, Z; Pareigis, AJ; Reis, G; Rodriguez, AH; Sánchez, AS; Saulay, M; Scheeren, TW; Zhou, X | 1 |
Bertz, H; Borde, JP; Busch, H; de With, K; Geibel-Zehender, A; Hug, M; Kaier, K; Kern, WV; Steib-Bauert, M; Vach, W | 1 |
Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS | 2 |
Caron, F; Choplin-Renard, J; Etienne, M; Pestel-Caron, M; Van Elslande, H | 1 |
Castanheira, M; Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS | 1 |
Long, TE; Williams, JT | 1 |
Arpi, M; Boel, JB; Bøggild, N; Gjørup, I; Hansen, SW; Jarløv, JO | 1 |
Chan, MC; Chang, FY; Lee, Y; Lin, JC; Lin, TY; Yang, YS; Yeh, KM | 1 |
Syed, YY | 1 |
Castanheira, M; Farrell, DJ; Jones, RN; Mills, JC | 1 |
Chen, CH; Chen, JB; Chiu, CH; Chuang, FR; Lee, CT; Liu, HT; Wu, CH; Yang, CC | 1 |
Ben Moussa, M; Lahlaoui, H | 1 |
Borde, JP; deWith, K; Feik, R; Hübner, J; Kaier, K; Kern, WV; Litterst, S; Ruhnke, M | 1 |
Lv, Z; Peng, GL; Su, JR | 1 |
Seifert, H | 1 |
Welte, T | 1 |
Bhardwaj, N; Biswas, D; Kakati, B; Kotwal, A; Thakuria, B | 1 |
Burmistrova, EN; Cherkasova, NA; Eremina, LV; Iakovlev, SV; Kolendo, SE; Sergeeva, EV; Suvorova, MP | 1 |
Cao, JM; Gan, TE; Ji, CH; Lv, B; Wu, JN; Wu, YH; Zhu, YX | 1 |
Barras, C; Jousselin, A; Kelley, WL; Lelong, E; Renzoni, A | 1 |
Cheng, J; Hou, X; Xu, Y; Xu, Z; Yang, Q; Zhang, H | 1 |
Kong, F; Mao, LL; O'Sullivan, MV; Wang, H; Xiao, M; Xu, YC; Zhang, H; Zhao, HR; Zhao, Y | 1 |
Dare, CR; Edwards, GF; Gould, IM; Lawes, T; López-Lozano, JM; Macartney, G; Nebot, C; Subbarao-Sharma, R | 1 |
Allaouchiche, B; Argaud, L; Bénet, T; Dananché, C; Dauwalder, O; Hernu, R; Vandenesch, F; Vanhems, P | 1 |
Hain, J; Hamouda, K; Leistner, M; Leyh, R; Menkel, H; Oezkur, M; Schimmer, C; Sinha, B | 1 |
Andresen, D; Harkness, J; Iredell, JR; Isaia, L; Marriott, D; Mubarak, N; O'Sullivan, M; Sandaradura, I; Zhou, F | 1 |
Burnham, CA; Dubberke, ER; Hink, T; Kwon, JH; Reske, KA; Seiler, S | 1 |
Airapetian, N; Ammenouche, N; Dupont, H; Friggeri, A; Levrard, M; Mahjoub, Y; Mammeri, H; Marciniak, S; Tinturier, F; Zogheib, E | 1 |
Nicolau, DP; Sutherland, CA | 1 |
Huntington, JA; Miller, BW; Nicolau, DP; Xiao, AJ | 1 |
James, D; Kearns, A; Livermore, DM; Mushtaq, S; Warner, M; Woodford, N | 1 |
Cleeve, V; Marshall, B; Oswald, T; Sarma, JB; Tate, D; Woolfrey, S | 1 |
Chia, JH; Hsu, PC; Kuo, AJ; Lee, CH; Lee, MH; Su, TY; Ye, JJ | 1 |
Baos, E; Candel, FJ; Nieto, M; Picazo, JJ | 1 |
Costello, AJ; Deshpande, LM; Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE | 1 |
Cillóniz, C; Liapikou, A; Torres, A | 1 |
Dare, CR; Gould, IM; Lawes, T; Lopez-Lozano, JM; Macartney, G; Nebot, CA; Subbarao-Sharma, R; Wares, KD | 1 |
Bhadoria, AS; Jindal, A; Kumar, M; Maiwall, R; Sarin, SK | 1 |
Scheeren, TW | 1 |
Jalava, J; Kärki, T; Lyytikäinen, O; Martelius, T; Möttönen, T; Ollgren, J | 1 |
Anderson, L; Dantes, R; Dolan, S; Dominguez, SR; Dowell, E; Epson, EE; Gould, CV; Guh, A; Hilden, JM; Hurst, A; Johnston, H; Limbago, B; Moulton-Meissner, H; Noble-Wang, J; Parker, SK; Pollack, LA; Rasheed, JK; Wang, F; West, K | 1 |
Castanheira, M; Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Rhomberg, PR; Sader, HS | 1 |
Cao, B; Chen, H; Chen, X; Chu, Y; Guo, P; Hu, B; Hu, Z; Jin, Y; Liao, K; Liu, W; Liu, Y; Luo, Y; Su, D; Tian, B; Wang, H; Wang, Y; Wang, Z; Xu, X; Zeng, J; Zhang, F; Zhang, R; Zhao, C; Zhou, C; Zhou, H; Zhuo, C; Zou, M | 1 |
Guivarch, E; Harpan, A; Montravers, P | 1 |
Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Sader, HS; Streit, JM | 1 |
Dewar, K; Edens, TJ; Manges, AR; Mehrotra, S; Miller, MA; Vincent, C | 1 |
Mouton, JW; Pea, F; Torres, A | 1 |
DiDiodato, G; McArthur, L | 1 |
Betts, J; Liakopoulos, A; Mevius, D; Oikonomou, O; Phee, LM; Wareham, DW | 1 |
Flamm, RK; Jones, RN; Mendes, RE; Sader, HS | 1 |
Braun, T; Carmeli, Y; Fallach, N; Schechner, V; Schwartz, D; Schwartz-Neiderman, A | 1 |
Aracil-García, B; Campos, J; Cuevas-Lobato, Ó; Fernández-Romero, S; Lara-Fuella, N; Oteo-Iglesias, J; Pérez-Grajera, I; Pérez-Vázquez, M | 1 |
Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N | 1 |
Bouza, E; Chalmers, JD; Freeman, J; Nord, CE; Wilcox, MH | 1 |
Bamford, C; Buys, H; Eley, B; Muloiwa, R | 1 |
Akagi, M; Kida, K; Kofuku, T; Komatsu, M; Mizutani, T; Nakai, I; Nakamura, T; Nishi, I; Nishio, H; Ono, T; Orita, T; Satoh, K; Sueyoshi, N; Toda, H; Wada, Y; Yamasaki, K; Zikimoto, T | 1 |
Gould, IM; Lawes, T; Lopez-Lozano, JM; Macartney, G; Nebot, CA; Sinclair, C; Subbarao-Sharma, R; Wares, KD | 1 |
Biglari, S; Hanafiah, A; Lopes, BS; Mohd Puzi, S; Rahman, M; Ramli, R | 1 |
Han, J; Jacob, J; Nelson, DB; Wu, J | 1 |
Djukanovic, N; Pejovic, A; Protic, D; Todorovic, Z; Toskovic, B; Zdravkovic, M | 1 |
Bassetti, M; Castanheira, M; Duncan, LR; Pfaller, MA | 1 |
Arias, CA; Carvajal, LP; Chambers, HF; Diaz, L; Garavito, JD; Miller, WR; Munita, JM; Nigo, M; Panesso, D; Rios, R; Tran, TT; Wanger, A; Weinstock, G | 1 |
Danziger, LH; Glowacki, RC; Horn, KS; Rodvold, KA | 1 |
Alberg, T; Blix, HS; Eriksen, HM; Holen, Ø; Neteland, MI; Smith, I | 1 |
Cheung, CM; Leonard, SN; Rybak, MJ | 1 |
Abrahamian, FM; Deblieux, PM; Emerman, CL; Kollef, MH; Kupersmith, E; Leeper, KV; Paterson, DL; Shorr, AF | 1 |
Chaudhary, M; Sehgal, R; Shrivastava, SM; Varughese, L | 1 |
Bassetti, M; Repetto, E | 1 |
Alquezar, A; Castro, P; Codina, C; Delgado, E; Marco, F; Martí, S; Martínez, JA; Mensa, J; Nicolás, JM; Soriano, A; Torres, A; Trilla, A; Vila, J | 1 |
Ballardini, M; Cerquetani, F; Comandini, E; Ippolito, G; Leone, S; Magrini, P; Meledandri, M; Narciso, P; Nicastri, E; Petrosillo, N; Pisanelli, C | 1 |
Herrera, ML; Jorgensen, JH; Lewis, JS; Prakash, V; Wickes, BL | 1 |
Micek, ST; Neuner, EA; Ritchie, DJ | 1 |
Ben Redjeb, S; Mbarek, M; Meddeb, B; Messadi, Aa; Thabet, L; Turki, A | 1 |
an der Heiden, M; Eckmanns, T; Jansen, A; Kleinkauf, N; Michels, H; Neumann, M; Weiss, B | 1 |
Ascerić, M; Custović, A; Hadzić, S; Zulcić-Nakić, V | 1 |
Hoban, DJ; Karlowsky, JA; Nichol, K; Noreddin, AM; Voth, D; Zhanel, GG | 1 |
Ariza, J; Dominguez, MA; Juan, C; Moya, B; Oliver, A; Peña, C; Pujol, M; Suarez, C; Tubau, F | 1 |
El Solh, A | 1 |
Cai, Y; Lin, L; Ling, JY; Sun, XF; Tong, GL; Xia, Y; Zhen, ZJ | 1 |
Rice, LB | 2 |
Ahn, SB; Byun, TJ; Cho, HS; Eun, CS; Han, DS; Jeon, YC; Kang, JO; Kim, TY; Sohn, JH | 1 |
Faccone, D; Galas, M; López, Y; Maggi, G; Marcano, D; Pasterán, F; Payares, D; Rapoport, M; Salgado, N; Sánchez, D; Spadola, E; Ugarte, C | 1 |
Gentry, LO; Wilkinson, LD | 1 |
Bartlett, KH; Chow, AW | 1 |
Clarke, AM; Zemcov, SJ | 1 |
Cheek, E; Citron, DM; Cubbon, M; Gerding, DN; Lippett, S; Llewelyn, M; Price, J; Sambol, SP | 1 |
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A | 1 |
Bulik, CC; Christensen, H; Nicolau, DP | 1 |
Bonten, MJ; Fluit, A; Nijssen, S; Top, J; van de Vijver, D; Willems, R | 1 |
Choe, KW; Jang, HC; Jeon, JH; Kim, EC; Kim, HB; Kim, NJ; Lee, S; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
Ansaldi, F; Bassetti, M; Bobbio Pallavicini, F; Fasce, R; Icardi, G; McDermott, JL; Molinari, MP; Mussap, M; Rebesco, B; Righi, E; Viscoli, C | 1 |
Bongiorno, D; Borbone, S; Campanile, F; Stefani, S | 1 |
Ge, Y; Juan, C; Moya, B; Oliver, A; Pérez, JL; Zamorano, L | 1 |
Cao, W; Gao, Y; Wu, Y; Yang, Y; Zhou, Q | 1 |
Leonard, SN; Rybak, MJ; Vidaillac, C | 1 |
Berger, MM; Bolay, S; Bugnon, D; Chapuis, TM; Chioléro, R; Décosterd, LA; Giannoni, E; Majcherczyk, PA; Moreillon, P; Schaller, MD | 1 |
Ishida, Y; Komori, T; Mizumachi, E; Nomura, K; Ohshiro, M; Sugai, M; Taniwaki, M; Yamashita, M | 1 |
Anca, Y; Soper, DE; Thurman, AR; White, CA | 1 |
Domelier-Valentin, AS; Mourens, C; Quentin, R; Savoyen, P; van der Mee-Marquet, N | 1 |
Aysev, D; Doğu, F; Erol Cipe, F; Ikincioğulları, A; Sucuoğlu, D | 1 |
Chopra, T; Fairfax, MR; Kaye, KS; Pogue, JM; Saely, S | 1 |
Schwab, F | 1 |
Cox, L; Hoban, DJ; Karlowsky, JA; Nichol, K; Noreddin, AM; Rossnagel, E; Zelenitsky, S; Zhanel, GG | 1 |
Altunsoy, A; Aypak, C; Azap, A; Balık, I; Ergönül, Ö | 1 |
Aarestrup, FM; Cavaco, LM; Hasman, H; Wasyl, D | 1 |
Bordon, JM; Clark, RB; Karlowsky, JA; Master, RN; Ramirez, J | 1 |
Alvarez, SD; Aragon, Mdel C; Cardenas, G; Cook, HJ; Moreno, A; Palomares-Alonso, F; Soto-Hernandez, JL | 1 |
Aziz, NA; Chong, CP; Lim, PP | 1 |
Alvarez-Espejo, T; Asensio, A; Bishopberger, C; Calbo-Torrecillas, F; Campayo, J; Canton, R; Fernandez-Crehuet, J; Hernandez Navarrete, M; Ramos, A; Vaque-Rafart, J | 1 |
Chandrasekhar, MR; Krishna, BV; Patil, A | 1 |
Cercenado, E; de Toro, M; García-Campello, M; Rojo-Bezares, B; Sáenz, Y; Torres, C; Undabeitia, E | 1 |
Agüero, J; Aracil, B; Borrell, N; Bou, G; Coelho, A; Conejo, MC; Fernández, A; Gozalo, M; Larrosa, N; Miró, E; Navarro, F; Oliver, A; Oteo, J; Pascual, A; Pomar, V; Rodríguez-Baño, J; Villar, M | 1 |
Borde, J; de With, K; Kern, WV; Stocker, H | 1 |
Abaev, IV; Anisimova, VA; Fursova, NK; Kovalev, IuN; Kuzhel'naia, EN; Priamchuk, SD; Svetoch, EA | 1 |
De Jesús, A; Hernández, L; Marcano, D; Torres, L | 1 |
Freeman, JT; Gamble, GD; Holland, DJ; McBride, SJ; Nisbet, MS; Taylor, SL; Williamson, DA | 1 |
Andremont, A; Arlet, G; Bernède-Bauduin, C; Guillemot, D; Papy, E; Schlemmer, B; Sollet, JP; Thiébaut, AC | 1 |
De Waele, JJ; Lipman, J; Paterson, DL; Roberts, JA; Udy, AA | 1 |
Hsueh, PR; Lee, YJ; Lin, YC; Liu, HY; Wu, HH | 1 |
Alberti, S; Beceiro, A; Cabot, G; Juan, C; Moyá, B; Oliver, A; Zamorano, L | 1 |
Bosques, F; Camacho-Ortiz, A; Garza-González, E; González, GM; Llaca-Díaz, JM; Muro, S; Rositas, F | 1 |
Ashiru-Oredope, D; Charani, E; Cooke, J; McNulty, C; Sharland, M | 1 |
Barl, P; Bedenić, B; Plečko, V; Sardelić, S; Uzunović, S; Vraneš, J | 1 |
Chen, CH; Chen, JB; Chuang, FR; Lee, CH; Lee, CT; Li, SH; Wu, CH; Yang, CC | 1 |
Chander, J; Garg, R; Gulati, N; Gupta, V; Krishnan, P; Kumarasamy, K | 1 |
Aguado, JM; Asensio, A; Blanes, M; Borrell, N; Bou, G; Carratalà, J; Cervera, C; Cisneros, JM; Fortún, J; Gavaldà, J; Gurguí, M; Len, O; Montejo, M; Muñoz, P; Pahissa, A; Rodríguez-Pardo, D; Torre-Cisneros, J | 1 |
Belabess, H; Honsali, Z; Jouhadi, Z; Lehlimi, M; Mdaghri, N; Najib, J; Sadiki, H; Zerouali, K | 1 |
Ghebremedhin, B | 1 |
Chen, A; Chen, L; Du, L; Shi, L; Yu, Y; Yuan, T; Zheng, J | 1 |
Arnold, HM; Hampton, NB; Hoban, A; Hoffmann, J; Hollands, JM; Juang, PH; Kollef, MH; McCormick, S; Micek, ST; Reichley, RM; Skrupky, LP; Smith, JR | 1 |
Cuthbertson, BH; Daneman, N; Fowler, RA; Sarwar, S | 1 |
Aspöck, C; Assadian, O; Berger, A; Hirschl, AM; Kohlhauser, C; Mustafa, S | 1 |
Blahová, J; Jezek, P; Králiková, K; Krćméry, V; Vaculíková, A | 1 |
Choi, SH; Choo, EJ; Chung, JW; Kim, BN; Kim, MN; Kim, NJ; Kim, TH; Kim, YS; Ryu, J; Woo, JH | 1 |
Sökeland, J | 1 |
Blumer, JL; Dul, M; O'Riordan, MA; Rosolowski, B; Salvator, A; Toltzis, H; Toltzis, P | 1 |
Balestrini, AA; Beric, V; Kibbler, CC; Quick, A; Stone, SP | 1 |
Chen, D; Cui, N; Du, B; Liu, D; Long, Y; Rui, X; Shi, Y; Wang, H | 1 |
Babayants, AA; Belyaev, DL; Kuznetsov, VP; Kuznetsova, SY; Markelova, EV; Silich, EV | 1 |
Jin, R; Kong, HS; Li, GX; Li, XY; Wang, W | 1 |
Burgmann, H | 1 |
Harris, AD; Kim, PW; Morris, JG; Perencevich, EN; Roghmann, MC; Strinivasan, A | 1 |
Allaouchiche, B; Boselli, E; Breilh, D; Chassard, D; Debon, R; Duflo, F; Saux, MC | 1 |
Draghi, DC; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C; Wenzel, RP | 1 |
Barza, M; Carling, P; Fung, T; Killion, A; Terrin, N | 1 |
Chaplain, C; Pangon, B | 1 |
Aymon, D; Bally, F; Bille, J; Chiolero, R; Cometta, A; Garbino, J; Glauser, MP; Greub, G; Kinge, T; Krawczyk, L; Lew, D; Romand, JA; Rubinstein, E; Schaller, MD; Stratchounski, L; Zanetti, G | 1 |
Gibson, G; Martin, H; McCoubrey, J; Poxton, IR; Starr, JM | 1 |
Toltzis, P | 1 |
Iakovlev, SV; Protsenko, DN; Romashov, OM | 1 |
Bell, JM; Jones, RN; Turnidge, JD | 1 |
Choi, SH; Chung, JW; Hyong Kim, T; Kim, NJ; Kim, YS; Lee, SO; Ryu, J; Woo, JH | 1 |
Chapman, TM; Perry, CM | 1 |
Arango, C; Bantar, C; Coassolo, MA; Duret, F; Fiorillo, A; Franco, D; Gomez, H; Heft, C; Krayeski, M; Oliva, ME; Salamone, F; Vesco, E | 1 |
Gürcan, S; Ozer, B; Shokrylanbaran, N; Tatman-Otkun, M | 1 |
Eggers, V; Fügener, K; Hein, OV; Heyes, MP; Kox, WJ; Rommelspacher, H; Spies, CD | 1 |
Arakawa, Y; Doi, Y; Ito, H; Kubota, T; Shibata, N; Wachino, J; Yagi, T; Yamane, K | 1 |
Avilova, ND; Mitrokhin, SD | 1 |
Bergeret, M; Boutros, N; Raymond, J | 1 |
Bhaskar, S; Sarda, AK | 1 |
Cryan, B; Kingston, M; O'Connor, KA; O'Donovan, M; O'Mahony, D; Twomey, C | 1 |
Byeon, JH; Hong, JY; Kim, YK; Lee, HJ; Pai, H | 1 |
Beceiro, A; Bou, G; Cartelle, M; del Mar Tomas, M; Dominguez, MA; Molina, F; Pertega, S; Velasco, D; Villanueva, R | 1 |
Betsunoh, H; Hamasuna, R; Nagano, M; Osada, Y; Sueyoshi, T; Takehara, T; Tsukino, H; Yakushiji, K | 1 |
Desimoni, MC; Esquivel, GP; Merino, LA | 1 |
Wong-Beringer, A | 1 |
Tumah, HN | 1 |
Chia, JH; Lee, CH; Liu, JW; Su, LH; Tsai, KT; Wu, TL | 1 |
Arnal, JM; Berger, P; Franceschini, B; Gainnier, M; Michel, F; Papazian, L; Sainty, JM | 1 |
Daschner, FD; Ebner, W; Heininger, A; Meyer, E; Rüden, H; Schwab, F | 1 |
Benbachir, M; Benchekroun, S; Harif, M; Loukili, A; Mahmal, L; Quessar, A | 1 |
Astagneau, P; Blanckaert, K; Carbonne, A; Cattoen, C; Chagnon, JL; Couzigou, C; Naas, T; Nordmann, P | 1 |
Chiarini, F; Conte, MP; D'Ettorre, G; Gallinelli, C; Orsi, GB; Scoarughi, GL; Venditti, M; Zamboni, I | 1 |
Iakovlev, SV; Iakovlev, VP | 1 |
Tumah, H | 1 |
Bonten, M; Florijn, A; Fluit, A; Nijssen, S; Top, J; Willems, R | 1 |
Barone, AA; Boszczowski, I; Costa, SF; Levin, AS; Nicoletti, C; Pinheiro, M; Puccini, DM; Soares, RE; Van der Heijden, IM | 1 |
Hawkey, PM; Livermore, DM | 1 |
Ho, SW; Hsueh, PR; Teng, LJ; Tseng, SP | 1 |
Kuti, JL; Nicolau, DP; Sun, HK | 1 |
Alberti, C; Chevret, S; Timsit, JF | 1 |
Arisoy, AE; Arisoy, ES; Gundes, S; Karaali, E; Kolayli, F; Sanic, A; Turker, G; Vahaboglu, H | 1 |
Chen, WH; Hsueh, PR; Luh, KT | 1 |
Bonsu, BK; Cohen, DM; Dorst, P; Sawicki, L; Shuler, L | 1 |
Iakovlev, SV; Romashov, OM | 1 |
Baraniak, A; Bossaert, L; Demey, HE; Gniadkowski, M; Goethaert, K; Goossens, H; Ieven, M; Jansens, H; Jorens, PG; Lammens, C; Van Herck, K; Van Looveren, M | 1 |
Heesemann, J; Hoffmann, H; Roggenkamp, A; Stürenburg, E | 1 |
Ambrose, PG; Ramphal, R | 1 |
Owens, RC; Rice, L | 1 |
Koulenti, D; Rello, J | 1 |
Benjamin, DK; Cotten, CM; Goldberg, RN; McDonald, S; Poole, K; Stoll, B | 1 |
Andrasi, M; Bagyi, K; Bognar, L; Gaspar, A; Klekner, A; Szabo, J | 1 |
Adeyi, B; DiNubile, MJ; Friedland, IR; Ginanni, JA; McCarroll, KA; Stratchounski, LS; Wood, CA; Woods, GL; Yakovlev, SV | 1 |
Bang, JW; Choe, KW; Kang, CI; Kim, EC; Kim, HB; Kim, NJ; Kim, SH; Oh, MD | 1 |
Flückiger, U; Hug, BL; Widmer, AF | 1 |
Chang, MT; Huang, CY; Jang, TN; Wang, CY; Wu, TH | 1 |
Gifford, AH; Kirkland, KB | 1 |
de Cueto, M; Hernández, JR; Muniain, MA; Navarro, MD; Pascual, A; Ríos, MJ; Rodríguez-Baño, J; Romero, L | 1 |
Lipman, J; Roberts, JA; Webb, SA | 1 |
Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK | 1 |
Avlamis, A; Daikos, GL; Markogiannakis, A; Papaparaskevas, J; Papapareskevas, J; Petrikkos, G; Stefanakos, G; Zissis, NP | 1 |
Bronze, MS; Cooper, TW; Gibbs, WJ; Greenfield, RA | 1 |
Castillo, F; Ellis, JM; Marte, P; Reyes, G; Rivera, L; Salazar, JC; Tejada, M | 1 |
Goldstein, FW | 1 |
Adelman, MH; Eubanks, DA; Paladino, JA; Schentag, JJ | 1 |
Kolár, M; Lovecková, Y; Santavá, L; Strojil, J; Urbánek, K | 1 |
Bonten, MJ; Bootsma, MC; Diekmann, O; Fluit, AC; Nijssen, S | 1 |
Egorova, S; Grimont, PA; Kaftyreva, L; Weill, FX | 1 |
Jung, DS; Ko, KS; Kwon, KT; Lee, MY; Lee, NY; Peck, KR; Song, JH; Suh, JY | 1 |
Du, M; Huang, Y; Zhuang, S | 1 |
Blot, SI; Decruyenaere, JM; Depuydt, PO; Vandijck, DM | 1 |
Braga, AL; Burattini, MN; Jukemura, EM; Medeiros, EA; Pereira, CA | 1 |
Arsura, EL; Bobba, RK; Bollu, M | 1 |
Berra, D; Chiarelli, C; Gattuso, G; Palvarini, L; Scalzini, A; Stradoni, R; Tomasoni, D | 1 |
Avdovenko, AL; Bodrova, NG; Sazhin, VP | 1 |
Gustafsson, I; Hallgren, H; Ripa, T | 1 |
Benselama, F; Branger, C; Charru, P; Eveillard, M; Hippeaux, MC; Lancien, E; Rufat, P | 1 |
Moreillon, P | 1 |
Fritsche, TR; Gorodecky, E; Jones, RN; Lodise, TP; Patel, N; Renaud-Mutart, A | 1 |
Decorby, M; Hoban, DJ; Karlowsky, JA; Nichol, K; Walkty, A; Zhanel, GG | 1 |
Khantipong, M; Pupaibool, J; Suankratay, C | 1 |
Boo, TW; Crowley, B; Roche, C; Walsh, F | 1 |
Conil, JM; Cougot, P; Decun, JF; Dieye, E; Georges, B; Houin, G; Lavit, M; Saivin, S; Samii, K; Seguin, T | 1 |
Laohavaleeson, S; Nicolau, DP; Tessier, PR | 1 |
Baĭgozina, EA; Sovalkin, VI | 1 |
Del Carmen Milán-Segovia, R; Lima-Rogel, V; López-Delarosa, A; Medina-Rojas, EL; Nieto-Aguirre, K; Noyola, DE; Romano-Moreno, S | 1 |
Belhadj, O; Ben-Achour, N; Ben-Moussa, M; Chouchani, C; Mahrouki, S | 1 |
Beaucaire, G; Caillaux, M; Deboscker, Y; Fourrier, A; Mouton, Y | 1 |
Daikos, GK; Dranidis, B; Giamarellou, H; Kosmidis, J; Mantopoulos, K; Stathakis, C | 1 |
Bergogne-Berezin, E; Joly-Guillou, ML; Verin-Prevost, C | 1 |
Ernest, KD; Magnussen, CR; Sammartino, MT | 1 |
Pranada, F; Pusztai-Markos, Z | 1 |
Bergogne-Berezin, E; Chabbert, YA; Cluzel, R; Courtieu, AL; Dabernat, H; Deforges, L; Duval, J; Witchitz, JL | 1 |
Acar, JF | 1 |
Bryskier, A; Le Noc, D; Le Noc, P | 1 |
Acar, JF; Bure, A; Christol, D; Courtieu, AL; Dabernat, H; Deforges, L; Duval, J; Kitzis, D; Le Van Thoi, J; Soussy, CJ | 1 |
Bodey, GP; Fainstein, V; Garcia, I; Rosenbaum, B; Wong, Y | 1 |
Stille, W | 1 |
Delisle, R; Pechère, JC | 1 |
Craig, WA; Vogelman, B | 1 |
Bentley, DW | 1 |
Pedler, SJ | 1 |
Follath, F | 2 |
Hirschmann, JV | 1 |
Moillo-Batt, A; Shacoori, ZT | 1 |
Balmayer, B; Bertrand, A; Despaux, E; Janbon, F; Jonquet, O; Lepeu, G; Santoni, A | 1 |
Breyer, S; Graninger, W; Pauser, G; Pichler, H; Pirich, U | 1 |
DiCostanzo, MB; Grieble, HG; Krause, SL; Pappas, SA | 1 |
Fernsebner, B | 1 |
Gutiérrez-Núñez, J; Harrington, PT; Ramirez-Ronda, CH | 1 |
Bassler, M; Daschner, FD; Goerke, C; Just, M | 1 |
Preheim, LC; Sanders, WE | 1 |
Smith, CR | 1 |
Grieco, MH | 1 |
Ducel, G; Lucain, C; Piffaretti, JC | 1 |
Montgomerie, JZ; Ota, JK | 1 |
Ciammaichella, A | 1 |
Badoual, J; Bergeret, M; Bingen, E; Brahimi, N; Doit, C; Gendrel, D; Raymond, J | 1 |
Babálová, M; Blahová, J; Hupková, M; Králiková, K; Krcméry, V | 1 |
Tilse, M; Tudehope, DI | 1 |
Isenberg, HD; Lam, S; Morthland, VH; Pfaller, MA; Singer, C; Tucci, V | 1 |
Deveney, CW; Deveney, KE; Grasley, A; Jobe, BA; Sheppard, BC | 1 |
Gianneli, D; Mentis, AF; Nikolopoulou, C; Tzelepi, E; Tzouvelekis, LS | 1 |
Acolet, D; Ahmet, Z; Houang, E; Hurley, R; Kaufmann, ME | 1 |
Chow, JW; Salacata, A | 1 |
Jones, RN; Marshall, SA | 1 |
Kumarasinghe, G; Lee, EJ; Leong, SO; Lye, WC | 1 |
Galanakis, N; Giamarellou, H; Voutsinas, D | 1 |
Mariotte, S; Nicolas, MH; Nordmann, P | 1 |
Gilliland, SS; Guay, DR; Larsson, AJ; Moody, JA; Rotschafer, JC; Vance-Bryan, K; Walker, KJ | 1 |
Daum, RS; Leitch, CD; Nachman, JP; Tenover, FC | 1 |
Swartz, MN | 1 |
Albanese, J; Domart, Y; Durbec, O; Gouin, F; Grès, JJ; Leroy, J; Martin, C; Papazian, L; Rollin, C; Veyssier, P | 1 |
Chen, ST; Tang, LM | 1 |
Auerbach, SB; Baltch, AL; Beck-Sague, C; Desjardin, E; Jarvis, WR; Nelson, DE; Rheal, C; Smith, RP | 1 |
Khoosal, M; Klugman, KP; Saunders, J | 1 |
Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R | 1 |
Verbist, L | 1 |
Spencer, RC | 1 |
Vogel, F | 1 |
Ariza, J; Gudiol, F; Martin, R; Pallares, R; Peña, C; Pujol, M | 1 |
Amaral, JL; Hollis, R; Jones, RN; Leme, IL; Pfaller, MA; Pignatari, A; Rodrigues, JN; Wey, S | 1 |
Croce, MA; Fabian, TC | 1 |
Fenelon, LE; MacGowan, AP; Reeves, DS; Smyth, EG; Speirs, GE; Speller, DC; Wilcox, MH | 1 |
Cohen, SH; Iglesias, T; Inciardi, JF; Jacobson, KL; King, JH; Lippert, WE; VanCouwenberghe, CJ | 1 |
Chiu, CT; Lien, JM; Lin, CJ; Lin, DY; Sheen, IS | 1 |
Archinal, W; Kacica, MA; Limberger, R; Preston, KE; Root, TP; Scarano, FJ; Steele, LM; Venezia, RA | 1 |
Holloway, WJ; Palmer, D | 1 |
Childs, S; Geckler, R; Sharifi, R | 1 |
Babálová, M; Krălíková, K; Krcméry, V; Kubonová, K | 1 |
Bert, F; Lambert-Zechovsky, N | 1 |
Liam, CK; Parasakthi, N; Riley, PA | 1 |
Belliveau, PP; Freeman, CD; Nicolau, DP; Nightingale, CH; Quintiliani, R; Tessier, PR | 1 |
Dopff, C; Gérard, A; Le Meins, V; Maurer, P; Witz, B | 1 |
Czerwionka-Szaflarska, M; Sobkowiak, E | 1 |
DeVente, J; Eckstein, EC; Rice, LB; Shlaes, DM | 1 |
Abumustafa, F; Cunha, BA; Domenico, P; Imambaccus, H; Qadri, SM; Tullo, DD; Ueno, Y | 1 |
Burman, LG; Haeggman, S; Tullus, K; Walder, M | 1 |
Bonczar, T; Haas, DW | 1 |
Culver, D; Danzing, L; Edwards, J; Gaynes, R; Stroud, L | 1 |
Daniel, M; Johnson, AP; Malde, M; Wallace, MR; Yousif, AA | 1 |
Goossens, H; Stes, P | 1 |
Kundra, P; Puri, J; Revathi, G; Talwar, V | 1 |
Bezbaruah, RL; Ghosh, AC; Paul, S; Roy, MK | 1 |
Blahová, J; Králiková, K; Krcméry, V; Kubonová, K | 1 |
Feeney, R; Jones, EM; Kirkpatrick, BL; MacGowan, AP; Reeves, DS | 1 |
Dvoretskiĭ, LI; Eremina, LV; Iakovlev, SV; Shakhova, TV | 1 |
Bonet, A; Castro, P; de Batlle, J; El-Ebiary, M; Sirvent, JM; Torres, A | 1 |
Impallomeni, M; Starr, JM | 1 |
Bouza, E; Lode, H; Mouton, Y; Wilson, WR | 1 |
Barrett, S; Bradbury, AW; Bulstrode, NW; Mansfield, AO; Nicolaides, AN; Stansby, G; Wolfe, JH | 1 |
Kontodimou, L; Malaka, E; Polydorou, F; Sofianou, D; Tsoulfa, S | 1 |
Berman, SJ; Farkas, SA; Geckler, RW; Sieger, B | 1 |
Fraise, AP | 1 |
Ho, SW; Hsueh, PR; Luh, KT; Teng, LJ; Yang, PC | 1 |
Derevianko, II; Khodyreva, LA | 1 |
Jones, RN; Marshall, SA; Pfaller, MA | 1 |
Eltahawy, AT | 1 |
Berry, P; Branger, C; Bruneau, B; Lambert-Zechovsky, N; Lesimple, AL | 1 |
Amyes, SG | 1 |
Aleksandrova, IA; Grudinina, SA; Rezvan, SP; Sidorenko, SV; Sterkhova, GV | 1 |
Besnier, JM; Leport, C | 1 |
Kasperk, R; Riesener, KP; Schumpelick, V | 1 |
Abachin, E; Arlet, G; Berche, P; Gaillot, O; Lecuru, F; Maruéjouls, C; Simonet, M | 1 |
Ambergen, AW; Bonten, MJ; Hayden, MK; Nathan, C; Slaughter, S; van Voorhis, J; Weinstein, RA | 1 |
Jones, RN | 1 |
Wilson, WR | 1 |
Hoogkamp-Korstanje, JA; Meis, JF; Verduyn Lunel, F | 1 |
Dvoretskiĭ, LI; Omel'ianovskiĭ, VV | 1 |
Ardanuy, C; Benedí, VJ; Domínguez, MA; Hernández-Allés, S; Liñares, J; Martínez-Martínez, L | 1 |
Sieger, B | 1 |
Akbal, H; Ozturk, R; Saribaş, S; Vahaboglu, H; Yucel, A | 1 |
Chang, TC; Ko, WC; Wu, HM; Wu, JJ; Yan, JJ | 1 |
Burns, JM; Dominick, D; Freeman, K; Horn, D; Lim, M; Mariano, N; Marks, S; Maurer, J; Rahal, JJ; Segal-Maurer, S; Urban, C | 1 |
Arango, A; Mattar, S; Muelle, C; Parodi, R; Pérez, D; Sánchez, L | 1 |
Burman, LG; Finnström, O; Haeggman, S; Isaksson, B | 1 |
Gniadkowski, M; Grzesiowski, P; Hryniewicz, W; Palucha, A | 1 |
Arbo, MD; Barefoot, L; Hariharan, R; Nathan, C; Snydman, DR; Weinstein, RA | 1 |
Brase, R; Heimesaat, M; Kljucar, S; Manhold, C; Timm, J; von Pritzbuer, E; von Rolbicki, U | 1 |
Gniadkowski, M; Mikiewicz, B; Pałucha, A | 1 |
Bradford, PA; Bush, K; Goering, RV; Nathan, C; Quinn, JP; Weinstein, RA; Wiener, J | 1 |
Chen, SC; Fung, CP; Lee, N; Lee, SC; Liu, PY; See, LC; Shieh, WB; Wang, TC | 1 |
Barr, JG; Hogg, GM; O'Neill, CA; Smyth, ET | 1 |
Beaucaire, G; Holzapfel, L; Le Fur, D; Léophonte, P; Martin, C; Nicolas, MH; Offenstadt, G; Péan, Y; Philippon, A; Renard, S | 1 |
Brown, RB; Ryczak, M; Sands, M | 1 |
Arroliga, AC; Fatica, C; Goldstein, LS; Gordon, SM; Hall, GS; Husni, RN; Stoller, JK | 1 |
Bartlett, ST; Keay, S; McCarter, RJ; Morris, JG; Oldach, DW; Pfundstein, J; Qaiyumi, SQ; Roghmann, MC; Schwalbe, RS; Schweitzer, E | 1 |
Cahen, P; Honderlick, P; Saheb, F | 1 |
Filka, J; Huttova, M; Kralinsky, K; Krcmery, V; Sagat, T; Tuharsky, J | 1 |
Polk, HC; Price, SA | 1 |
Iakovlev, VP | 2 |
Arima, Y; Kajiwara, H; Kawai, K; Kusachi, S; Nagao, J; Nakamura, Y; Saida, Y; Sumiyama, Y; Yoshida, Y | 1 |
Doré, P; Fauchère, JL; Ferrand, E; Grollier, G; Hira, M; Robert, R | 1 |
Deblangy, C; Decré, D; Fichelle, A; Joly-Guillou, ML; Kosmann, MJ; Lucet, JC; Pernet, M; Régnier, B | 1 |
Brown, N; Coni, N; Ludlam, H; Owen, G; Redpath, C; Sule, O | 1 |
Akhmedova, LI; Beloborodov, VB; Bogomolova, NS; Bol'shakov, LV; Dekhnich, AV; Iakovlev, VP; Karabak, VI; Malikov, VE; Pavlova, MV; Polikarpova, SV; Rudnov, VA; Sidorenko, SV; Strachunskiĭ, LS | 1 |
Beloborodova, NV; Biriukov, AV; Krutskikh, EN; Kurchavov, VA; Rogatina, EL; Vostrikova, TIu | 1 |
Giamarellou, H | 1 |
Hoang, LM; Stiver, G | 1 |
Hoban, DJ; Jones, RN; Pfaller, MA; Ramphal, R | 1 |
Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P; Tsitsika, A; Tympanidou, C | 1 |
Arlet, G; Donay, L; Herrmann, J; Lagrange, PH; Nadjar, D; Philippon, A; Rouveau, M; Verdet, C | 1 |
Al-Eidan, FA; Kearney, MP; McElnay, JC; Scott, MG | 1 |
Dimopoulou, H; Miriagou, V; Platsouka, E; Tzelepi, E; Tzouvelekis, LS | 1 |
Chuang, YC; Ko, WC; Lee, HC; Liu, CC; Wu, JJ | 1 |
Siostrzonek, P; Thalhammer, F | 1 |
Balstrini, A; How, A; Kibbler, C; Stone, S | 1 |
Bradley, SJ | 1 |
Boucher, BA; Croce, MA; Fabian, TC; Hanes, SD; Herring, V; Pritchard, E; Wood, GC | 1 |
Auten, R; Benjamin, DK; Fisher, RG; McKinney, RE; Ross, K | 1 |
Cross, JM; May, AK; McGwin, G; Melton, SM; Moser, SA; Rue, LW | 1 |
Trivalle, C | 1 |
Butkevich, OM; Vinogradova, TL | 1 |
Felts, AG; Grainger, DW; Slunt, JB | 1 |
Carmeli, Y; Castro, J; Eliopoulos, GM; Samore, MH | 1 |
Patterson, JE | 1 |
Kan'ovska, E; Khitsova, S; Rosmanova, R; Sredkova, M; V'lkova, A | 1 |
Aschbacher, R; De Fina, G; Lang, A; Meyer, R; Paluselli, P; Rizza, F; Zelger, P | 1 |
Bush, K; Mariano, N; Montenegro, D; Queenan, AM; Rahal, JJ; Rahman, N; Urban, C | 1 |
Kunishima, Y; Matsukawa, M; Takahashi, S; Takeyama, K; Tsukamoto, T | 1 |
Becerril, B; Caballero-Granado, FJ; Cisneros, JM; Cuberos, L; Moreno, I; Pachón, J | 1 |
Hryniewicz, W; Skoczyńska, A; Szczypa, K | 1 |
Amicosante, G; Lombardi, G; Luzzaro, F; Mantengoli, E; Orlandi, V; Orsatti, A; Perilli, M; Rossolini, GM; Toniolo, A | 1 |
Noy, A; Orni-Wasserlauf, R; Siegman-Igra, Y; Sorkine, P | 1 |
Andresen, DN; Collignon, PJ | 1 |
McNabb, JJ; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
Alvarez-Lerma, F; Barcenilla, F; Insausti-Ordeñana, J; Jordá-Marcos, R; Maraví-Poma, E; Martínez-Pellús, A; Nava, J; Palomar, M; Torres-Martí, A | 1 |
Andre, C; Arpin, C; Dubois, V; Frigo, C; Melon, B; Melon, M; Quentin, C | 1 |
Malacarne, P; Rossi, C | 1 |
Bradley, SF; Mody, L; Muder, RR; Strausbaugh, LJ | 1 |
Calil, R; Marba, ST; Tresoldi, AT; von Nowakonski, A | 1 |
Lacy, MK; McNabb, J; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
Alvarez-Lerma, F; Cerda, E; Olaechea, P; Palomar, M; Sierra, R | 1 |
Bassetti, D; Bassetti, M; Mantero, E | 1 |
Baquero, F; Blázquez, J; Morosini, MI; Negri, MC | 1 |
Chang, FY; Lin, JC; Peng, MY; Yeh, KM | 1 |
Servais, H; Tulkens, PM | 1 |
Berger, R; Gruenewald, T; Leibovici, L; Milo, G; Paul, M; Pitlik, SD; Samra, Z; Yahav, J; Yehezkelli, Y | 1 |
Campillo, SB; Dupeyron, C; Leluan, G; Mangeney, N; Richardet, JP | 1 |
Chow, C; Kumarasinghe, G; Tambyah, PA | 1 |
Block, C; Ferderber, N; Roval, V; Schwaber, MJ; Shapiro, M; Simhon, A | 1 |
Barton, MD | 1 |
Ho, SW; Hsueh, PR; Jean, SS; Luh, KT; Teng, LJ | 1 |
Alegre-Martin, J; Odenholt, I; Petermann, W; Phillips, MJ; Tack, K; Trostmann, U; Welling, L; Willcox, PA | 1 |
Empey, KM; Evans, ME; Rapp, RP | 1 |
Fennewald, M; Girlich, D; Leelaporn, A; Naas, T; Nordmann, P; Poirel, L | 1 |
Rudakova, AV | 1 |
Iakovlev, SV | 1 |
Badolati, A; Fontán, PA; Gammella, D; Maskin, B; Spinedi, EG | 1 |
Adair, CG; Byers, LM; Crowe, M; Feron, B; Gorman, SP; Jones, DS; McCarthy, GJ; Milligan, KR; Webb, HC | 1 |
Figgitt, DP; Lamb, HM; Ormrod, D; Scott, LJ | 1 |
Carmeli, Y; Cosgrove, S; Harbarth, S | 1 |
Bisson, G; Edelstein, PH; Fishman, NO; Lautenbach, E; Patel, JB | 1 |
Byrnes, GB; Dartnell, JG; Ioannides-Demos, LL; Kirsa, SW; Korman, TM; Lord, JA; Munafo, L; Robertson, MB | 1 |
Beloborodov, VB | 1 |
Heister, R | 1 |
Chambers, S; Down, G; Dulake, C; Mortimer, PR; Noble, CJ; Palfreyman, J | 1 |
Marget, W | 1 |
Cushing, RD | 1 |
Lacey, RW | 1 |
Kass, EH; Rosner, B; Shapiro, M; Townsend, TR | 1 |
Williams, RF | 1 |
Adam, D | 1 |
Cockx, E; Iarchy, J | 1 |
Gorbach, SL; Tally, FP | 1 |
Rosaschino, F | 1 |
Krämer, J; Maassen, H; Rosin, H | 1 |
Chow, C; Kumarasinghe, G; Liew, HY | 1 |
Cobb, DK; Schleupner, CJ | 1 |
Kusachi, S; Sumiyama, Y | 1 |
Casiraghi, S; Caspani, P; Germiniani, R; Pace, M; Rosina, M; Tajana, A; Trabucchi, E | 1 |
Baquero, F; Fernández-Rodríguez, A; Pérez-Díaz, JC; Picazo, JJ; Reguera, JA | 1 |
Alonso, T; Liñares, J; Pérez, JL | 1 |
Bauernfeind, A; Becker-Boost, E; Fiehn, A; Finger, H; Ritter, E; Stöcker, H; Wirsing von König, CH | 1 |
Carbon, C | 1 |
Hallén, I; Larsson, P; Sandberg, T | 1 |
Baquero, F; Canton, R; Gomez-Alferez, A; Loza, E; Martinez-Beltran, J | 1 |
Abe, S | 1 |
Sheagren, J | 1 |
Aronsson, B; Eriksson, S | 1 |
Imamura, Y; Kodama, T; Matsuura, Y; Miyamoto, K; Murakami, Y; Sewake, H; Takesue, Y; Tsumura, H; Yokoyama, T | 1 |
Dixon, CM; McLean, AP; Meakins, JL; Yee, J | 1 |
Mulgrave, L | 1 |
Zimmerman, RK | 1 |
Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP | 1 |
Clark, N; Cooksey, R; Gay, E; Swenson, J; Thornsberry, C | 1 |
Pennington, JE | 1 |
Kotanagi, H; Koyama, K; Kusaka, H; Nakagomi, O; Narisawa, T; Takahashi, M; Yamazaki, Y | 1 |
de Mier, C; Fernández, A; Herran, I; Marcenac, FM | 1 |
Avlamis, A; Giamarellou, H; Mavroudis, T; Voutsinas, D | 1 |
Besbes, M; Brun-Buisson, C; Legrand, P; Lemaire, F; Meakins, JL; Montravers, F; Rauss, A; Richard, C; Soussy, CJ | 1 |
de Lalla, F; Ortisi, G; Pagano, A; Privitera, G; Rinaldi, E; Rizzardini, G; Santoro, D; Scarpellini, P | 1 |
Donowitz, GR | 1 |
Asanuma, Y; Koyama, K; Nakagomi, O; Narisawa, T; Sato, Y; Takahashi, M; Tobita, M | 1 |
Greco, T | 1 |
Ariza, J; deCelis, G; Gudiol, F; Pallares, R; Pinto, J | 1 |
Ansquer, M; Brun-Buisson, C; Duval, J; Legrand, P; Montravers, F; Philippon, A | 1 |
Gaston, MA | 1 |
Nicolle, LE | 1 |
Gabrielová, A; Havlík, J; Krcméry, V | 1 |
Antal, M; Kapániková, V; Krcméry, V; Lonská, V; Nanista, D; Seckárová, A; Skacániová, H; Sláma, J; Zikmundová, V | 1 |
Knothe, H | 1 |
Cheng, DL; Fung, CP; Juang, YC; Liu, CY; Wang, LS | 1 |
Cave, J; Magnussen, CR | 1 |
Cooley, DA; Gentry, LO; Zeluff, BJ | 1 |
Funada, H; Machi, T; Matsuda, T | 1 |
Safran, C | 1 |
Alvarez, ME; Bodey, GP; Hsu, KC; Rolston, KV | 1 |
Roselle, GA | 1 |
Godoy, J; Huerta, H; Pizarro, E; Silva, J | 1 |
Bauernfeind, A; Dietlein, G; Naber, KG; Wittenberger, R | 1 |
File, TM; Tan, JS | 1 |
Fry, DE | 1 |
Nonomura, M; Yoshida, O | 1 |
Grzybek-Hryncewicz, K; Ruczkowska-Struzik, J | 1 |
Quenzer, RW | 1 |
Chryssouli, Z; Giamarellou, H; Sahin, A | 1 |
Shanson, DC | 1 |
Chaisson, RE; Leoung, GS; Mills, J | 1 |
Moellering, RC | 1 |
Figini, G; Germiniani, R; Mastropasqua, E; Mauri, J; Rosina, M | 1 |
Starr, SE | 1 |
Opferkuch, W | 1 |
Ward, TT | 1 |
Neu, HC | 1 |
Guenthner, SH; Norris, SM; Wenzel, RP | 1 |
Waldvogel, FA | 1 |
Dette, GA; Knothe, H; Shah, PM | 1 |
Shotts, N; Stirland, RM | 1 |
Benner, EJ; Kayser, FH | 1 |
Koenig, MG | 1 |
Hollinger, A; Kayser, FH | 1 |
Barrett, FF; Ewing, WH; Finland, M; Kass, EH; Wilfert, JN | 1 |
Bernadou, A; Bilski-Pasquier, G; Bousser, J; Dao, C; Gerbal, R; Zittoun, R | 1 |
Klein, W; Krämer, J; Lenz, G; Steinhaus, M | 1 |
Bruun, JN; Mulholland, SG | 1 |
Sanford, JP | 2 |
Courtieu, AL; Lecluse, J; Moinard, D; Sedallian, A | 1 |
Wise, RI | 1 |
Plorde, JJ; Sherris, JC | 1 |
Acar, JF; Bastin, R; Worms, R | 1 |
Acar, JF; Chabbert, YA; Courvalin, P | 1 |
Brumfitt, W | 1 |
Benner, EJ | 1 |
Adler, JL; Burke, JP; Finland, M; Martin, DF | 1 |
Ross, S | 1 |
Barber, M | 1 |
Brayton, RG; Louria, DB; MacLean, RA | 1 |
90 review(s) available for cephalosporin c and Cross Infection
Article | Year |
---|---|
Ceftolozane-tazobactam in nosocomial pneumonia.
Topics: Adult; Cephalosporins; Cross Infection; Healthcare-Associated Pneumonia; Humans; Pseudomonas Infections; Tazobactam | 2022 |
Modifiable risk factors for multidrug-resistant Gram-negative infection in critically ill burn patients: a systematic review and meta-analysis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Burns; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Drug Resistance, Multiple; Gram-Negative Bacterial Infections; Humans; Hydrotherapy; Intensive Care Units; Penicillins; Respiration, Artificial; Risk Factors; Urinary Catheters; Vascular Access Devices | 2019 |
Cost-effectiveness of selective digestive decontamination (SDD) versus selective oropharyngeal decontamination (SOD) in intensive care units with low levels of antimicrobial resistance: an individual patient data meta-analysis.
Topics: Administration, Topical; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Carrier State; Cephalosporins; Colistin; Cost-Benefit Analysis; Cross Infection; Decontamination; Drug Resistance, Microbial; Female; Gastrointestinal Tract; Health Care Costs; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Netherlands; Oropharynx; Randomized Controlled Trials as Topic; Tobramycin | 2019 |
Extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: critical tools for antibiotic resistance pattern.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
Valvular Heart Disease in Adults: Infective Endocarditis.
Topics: Anti-Bacterial Agents; Blood Culture; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Echocardiography; Endocarditis; Endocarditis, Bacterial; Gentamicins; Heart Valve Prosthesis; Humans; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 2017 |
[Antibiotic stewardship in a basic care hospital : A retrospective observational study].
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Cephalosporins; Clostridioides difficile; Cross Infection; Escherichia coli; Hospitals; Humans; Retrospective Studies | 2018 |
Risk factors for hospitalized patients with resistant or multidrug-resistant
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Risk Factors; Vancomycin | 2018 |
Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Humans; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Retrospective Studies; Treatment Outcome | 2018 |
Off-label use of ceftaroline fosamil: A systematic review.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Community-Acquired Infections; Cross Infection; Endocarditis, Bacterial; Healthcare-Associated Pneumonia; Humans; Meningitis; Off-Label Use | 2019 |
Ceftobiprole for the treatment of pneumonia.
Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Administration Schedule; Humans; Pneumonia, Bacterial; Renal Insufficiency | 2019 |
Possible clinical indications of ceftobiprole.
Topics: Anti-Bacterial Agents; Bacterial Infections; Catheter-Related Infections; Cephalosporins; Cross Infection; Diabetic Foot; Fever of Unknown Origin; Humans; Inpatients; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections | 2019 |
Safety and tolerability of ceftobiprole.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Neutropenia; Pneumonia, Bacterial; Pseudomonas aeruginosa; Streptococcus pneumoniae | 2019 |
Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia.
Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Cross Infection; Dose-Response Relationship, Drug; Humans; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Treatment Outcome | 2013 |
Cephalosporins currently in early clinical trials for the treatment of bacterial infections.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Cross Infection; Drug Approval; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2014 |
Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Approval; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pneumonia, Bacterial; Prodrugs | 2014 |
Ceftobiprole for the treatment of pneumonia: a European perspective.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Europe; Humans; Pneumonia, Bacterial; Treatment Outcome | 2015 |
Ceftobiprole medocaril in the treatment of hospital-acquired pneumonia.
Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Cross Infection; Drug-Related Side Effects and Adverse Reactions; Enterobacteriaceae; Enterococcus; Europe; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Staphylococcus aureus; Treatment Outcome | 2015 |
Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Humans; Pneumonia, Ventilator-Associated; Risk Factors; Severity of Illness Index | 2016 |
Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations.
Topics: Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Community-Acquired Infections; Critical Illness; Cross Infection; Dose-Response Relationship, Drug; Drug Dosage Calculations; Half-Life; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Microbial Sensitivity Tests; Monte Carlo Method; Pediatrics; Pneumonia; Renal Insufficiency | 2016 |
Role of cephalosporins in the era of Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Europe; Humans; Incidence; Risk Assessment | 2017 |
Pharmacokinetic drug evaluation of ceftobiprole for the treatment of MRSA.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Critical Illness; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Staphylococcal Infections | 2017 |
Health care-associated pneumonia: identification and initial management in the ED.
Topics: Acetamides; Age Distribution; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Emergency Treatment; Ertapenem; Female; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Patient Care Team; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Respiration, Artificial; Risk Factors; Severity of Illness Index; Tigecycline | 2008 |
[Diagnostic and therapeutic management of Gram-negative infections].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Disease Management; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Italy; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
New antibiotics for healthcare-associated pneumonia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin | 2009 |
Ceftobiprole: a new broad spectrum cephalosporin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Cross Infection; Drug Interactions; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Treatment Outcome | 2009 |
[Antibiotics: new and old drugs, rational prescription].
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Biological Availability; Cephalosporins; Colistin; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Practice Patterns, Physicians' | 2012 |
[Extended-spectrum of beta-lactamases (ESBL): yesterday ESBL: and today ESBL, carbapenemase-producing and multiresistant bacteria].
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; Disinfection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Infant, Newborn | 2012 |
Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cephalosporins; Clinical Trials as Topic; Cross Infection; Decontamination; Digestive System; Disease Transmission, Infectious; Drug Resistance, Bacterial; Enterobacteriaceae; Europe; Fluoroquinolones; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Neomycin; Nystatin; Odds Ratio; Oropharynx; Polymyxins; Prevalence; Primary Prevention; Pseudomonas aeruginosa; Randomized Controlled Trials as Topic; South Africa; Tobramycin; United States; Vancomycin | 2013 |
Colonization with antibiotic-resistant Gram-negative bacilli in the neonatal intensive care unit.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Italy; Male; Pregnancy | 2003 |
[Cefepime in the treatment of hospital-acquired pneumonia].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Candida; Cefepime; Cephalosporins; Cross Infection; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Middle Aged; Pneumonia; Treatment Outcome | 2003 |
Cefepime: a review of its use in the management of hospitalized patients with pneumonia.
Topics: Cefepime; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial | 2003 |
Treating serious infections: focus on cefepime.
Topics: Cefepime; Cephalosporins; Cross Infection; Humans; Neutropenia; Pneumonia, Bacterial | 2004 |
[Study of cefepime in Russia].
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Humans | 2004 |
[Role of cefepime in the treatment of hospital-acquired pneumonia].
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Humans; Pneumonia, Bacterial | 2005 |
Extended-spectrum beta-lactamases and clinical outcomes: current data.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Treatment Outcome | 2006 |
Hospital-based strategies for combating resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Infection Control | 2006 |
Antimicrobial resistance in gram-positive bacteria.
Topics: Animals; beta-Lactamase Inhibitors; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterococcus faecalis; Gastrointestinal Tract; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin Resistance | 2006 |
Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.
Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin | 2006 |
[Nosocomial urinary tract infection in adults].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cross Infection; Humans; Penicillins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Urinary Catheterization; Urinary Tract Infections | 2006 |
Cefepime versus ceftazidime: considerations for empirical use in critically ill patients.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Resistance; Economics, Pharmaceutical; Humans; Pneumonia, Bacterial | 2007 |
Antimicrobial symposium. Part IV. Cephalosporins.
Topics: Anti-Infective Agents; Cephalosporins; Chlamydophila pneumoniae; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus; Humans; Legionella pneumophila; Mycoplasma pneumoniae; Staphylococcus aureus; Staphylococcus epidermidis | 2006 |
Combating resistance in a challenging, changing environment.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Cross Infection; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 2007 |
New and emerging treatment of Staphylococcus aureus infections in the hospital setting.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase III as Topic; Cross Infection; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcal Infections; Staphylococcus aureus | 2008 |
Pharmacokinetic and pharmacodynamic profile of ceftobiprole.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Humans; Monte Carlo Method; Pneumonia; Skin Diseases, Bacterial | 2008 |
Changing patterns of hospital infections: implications for therapy. Changing concepts and new applications of antibiotic pharmacokinetics.
Topics: Anti-Bacterial Agents; Bacteria; Bile; Blood Proteins; Body Fluids; Cephalosporins; Cross Infection; Humans; Kidney; Kinetics; Microbial Sensitivity Tests; Molecular Weight; Protein Binding; Tissue Distribution | 1984 |
Bacterial pneumonia in the elderly: clinical features, diagnosis, etiology, and treatment.
Topics: Aged; Ampicillin; Bacterial Infections; Cephalosporins; Cross Infection; Haemophilus Infections; Humans; Klebsiella Infections; Leukocyte Count; Male; Mucus; Penicillins; Pneumonia; Pneumonia, Pneumococcal; Sputum; Staphylococcal Infections | 1984 |
Considerations regarding clinical safety and tolerability of antibiotics in serious and nosocomial infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chemistry, Pharmaceutical; Cross Infection; Dose-Response Relationship, Drug; Drug Hypersensitivity; Drug Interactions; Hearing Disorders; Humans; Kidney Diseases | 1981 |
Antibiotic resistance.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cell Wall; Cephalosporins; Cross Infection; Hexosyltransferases; Humans; Methicillin; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; R Factors; Staphylococcus | 1982 |
Cephalosporin therapeutics for intensive care infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Severity of Illness Index; Tissue Distribution; Treatment Outcome | 1993 |
Hospital-acquired infections: diseases with increasingly limited therapies.
Topics: Candidiasis; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1994 |
[Parenteral cephalosporins for the treatment of lower respiratory tract infections].
Topics: Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Cross Infection; Humans; Infusions, Intravenous; Injections, Intravenous; Pneumonia | 1993 |
Risk of diarrhoea, Clostridium difficile and cefotaxime in the elderly.
Topics: Aged; Cefotaxime; Cephalosporins; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Forecasting; Humans; Risk Factors | 1997 |
The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerations.
Topics: Adolescent; Adult; Cefotaxime; Cephalosporins; Child; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Humans; Microbial Sensitivity Tests; Middle Aged | 1997 |
[Clinical implications of antibiotic resistance of enterococci].
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Risk Factors | 1997 |
Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes.
Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Humans | 1998 |
The role of fourth-generation cephalosporins in the treatment of serious infectious diseases in hospitalized patients.
Topics: Bacteremia; Cephalosporins; Cross Infection; Humans; Severity of Illness Index; Treatment Outcome | 1998 |
[Differential use of cephalosporins in treatment of upper and lower respiratory tract infections].
Topics: Administration, Oral; Age Factors; Aged; Biological Availability; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections | 1998 |
Prophylactic and therapeutic use of antibiotics in pelvic surgery.
Topics: Antibiotic Prophylaxis; Cephalosporins; Cross Infection; Female; Genital Diseases, Female; Humans; Pelvic Inflammatory Disease; Pelvis; Postoperative Complications; Urinary Tract Infections | 1999 |
[Analysis of the 10-year use in Russia of cefoperazone, a third-generation cefalosporin, in the treatment of hospital infections].
Topics: Adult; Cefoperazone; Cephalosporins; Child; Cross Infection; Economics, Pharmaceutical; Follow-Up Studies; Humans; Infant, Newborn; Microbial Sensitivity Tests; Russia; Treatment Outcome | 1999 |
[The use of cefepime for treating patients with severe hospital infections].
Topics: Bacterial Infections; Cefepime; Cephalosporins; Clinical Trials as Topic; Cross Infection; Female; Humans; Male | 1999 |
Fourth generation cephalosporins in the antimicrobial chemotherapy of surgical infections.
Topics: Abdomen; Appendicitis; Cephalosporins; Cross Infection; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Pelvic Inflammatory Disease; Surgical Wound Infection | 1999 |
Antibiotic utilization: is there an effect on antimicrobial resistance?
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Enterococcus; Humans; Klebsiella pneumoniae; Risk; Vancomycin Resistance | 2001 |
Antimicrobial prophylaxis for orthopaedic surgery.
Topics: Antibiotic Prophylaxis; Blood-Borne Pathogens; Cephalosporins; Cross Infection; Drug Administration Schedule; Fractures, Closed; Fractures, Open; Humans; Methicillin Resistance; Orthopedic Procedures; Staphylococcal Infections; Surgical Wound Infection | 2001 |
Strategies for antibiotic selection in empirical therapy.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Decision Making; Humans | 2000 |
Antibiotic resistance in hospital infections: the role of newer cephalosporins.
Topics: beta-Lactam Resistance; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Humans | 2000 |
The effect of an antimicrobial formulary change on hospital resistance patterns.
Topics: Cephalosporin Resistance; Cephalosporins; Cross Infection; Formularies, Hospital as Topic; Hospitals, University; Humans; Kentucky; Retrospective Studies; Trauma Centers | 2002 |
[Fourth generation cephalosporins in treating severe hospital infections: pharmacoeconomic aspects].
Topics: Cephalosporins; Cross Infection; Drug Resistance, Microbial; Economics, Pharmaceutical; Humans; Microbial Sensitivity Tests | 2001 |
[Modern role of cephalosporin antibiotics for treating infections in the hospital].
Topics: Bacterial Infections; Cephalosporins; Cross Infection; Humans | 2001 |
Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.
Topics: Animals; Bacteria; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans | 2002 |
Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Cross Infection; Drug Utilization; Enterococcus; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Intestines; United States; Vancomycin Resistance | 2002 |
[A choice of antibacterial chemotherapy for nosocomial infections caused by pathogens producing broad-spectrum beta-lactamases].
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cross Infection; Humans | 2001 |
[Preventive and therapeutic application possibilities of newer antibiotics (author's transl)].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteroides; beta-Lactamases; Cefoxitin; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Haemophilus influenzae; Humans; Surgical Wound Infection | 1979 |
Antibiotics in surgery.
Topics: Anti-Bacterial Agents; Bacterial Infections; Biliary Tract Diseases; Burns; Catheterization; Cephalosporins; Clindamycin; Colon; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Genital Diseases, Female; Gentamicins; Humans; Liver Abscess; Penicillin Resistance; Penicillins; Peritonitis; Postoperative Complications; Sepsis; Sulfamethoxazole; Surgical Procedures, Operative; Tetracyclines; Trimethoprim | 1975 |
[Antistaphylococcal activity of gentamicin].
Topics: Cephalosporins; Cross Infection; Drug Resistance, Microbial; Framycetin; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Neomycin; Paromomycin; Rifampin; Staphylococcal Infections; Staphylococcus; Streptomycin; Virginiamycin | 1975 |
A study of the etiologies and treatment of nosocomial pneumonia in a community-based teaching hospital.
Topics: Adult; Aged; Aged, 80 and over; Cephalosporins; Cross Infection; Female; Haemophilus Infections; Haemophilus influenzae; Hospital Bed Capacity, 100 to 299; Hospitals, Community; Hospitals, Teaching; Hospitals, Veterans; Humans; Male; Middle Aged; Pneumococcal Infections; Pneumonia; Retrospective Studies; Single-Blind Method; Virginia | 1992 |
[Enterococci: acquired antibiotic resistance].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Incidence; Urinary Tract Infections; Vancomycin | 1992 |
Use of third-generation cephalosporins. Staphylococci.
Topics: Carrier State; Cephalosporins; Cross Infection; Humans; Premedication; Staphylococcal Infections | 1991 |
Approach to therapy of respiratory infections in the critical care setting.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Humans; Intensive Care Units; Metronidazole; Pneumonia | 1990 |
Third generation cephalosporins.
Topics: Bacteria; Cephalosporins; Cross Infection; Humans; Meningitis; Pseudomonas Infections; Structure-Activity Relationship | 1989 |
Enterobacter: an emerging nosocomial pathogen.
Topics: Bacteriophage Typing; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Sepsis; Serotyping | 1988 |
The selection of microorganisms for treatment with broad-spectrum cephalosporins.
Topics: Bacterial Infections; Cephalosporins; Cross Infection; Humans | 1988 |
Empiric antimicrobial therapy of serious urinary tract infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Candidiasis; Cephalosporins; Cross Infection; Drug Therapy, Combination; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Penicillins; Pyelonephritis; Urinary Catheterization; Urinary Tract Infections | 1986 |
Third generation cephalosporin antibiotics in surgical practice.
Topics: Bacteria; Bacterial Infections; Central Nervous System Diseases; Cephalosporins; Chemical Phenomena; Chemistry; Cholecystitis; Clinical Trials as Topic; Cross Infection; Female; Genital Diseases, Female; Humans; Premedication; Surgical Wound Infection | 1986 |
[Chemotherapy of urinary tract infections caused by Pseudomonas].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Humans; Penicillins; Pseudomonas; Pseudomonas Infections; Urinary Tract Infections | 1986 |
Antimicrobial therapy of bacterial sepsis in the newborn infant.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacteria; Cephalosporins; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Infant Mortality; Infant, Newborn; Penicillin Resistance; Penicillins; Sepsis; Thienamycins | 1985 |
[Classification, diagnosis and therapy of pneumonia].
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antibody Specificity; Biopsy; Cefoxitin; Cephalosporins; Clindamycin; Cross Infection; Erythromycin; Humans; Legionnaires' Disease; Lung; Metronidazole; Penicillin G; Pneumonia; Radiography, Thoracic; Serologic Tests; Sputum; Tetracycline | 1985 |
Postoperative infection in urologic surgery.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Bacteriuria; Catheters, Indwelling; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Postoperative Complications; Prostate; Prostatectomy; Pyuria; Risk; Sepsis; Time Factors; Urinary Catheterization; Urinary Tract Infections; Urologic Diseases | 1985 |
Staphylococcal infections--treatment and control.
Topics: Carrier State; Cephalosporins; Cross Infection; Hospitalization; Humans; Infant, Newborn; Infant, Newborn, Diseases; Lysostaphin; Osteomyelitis; Penicillins; Staphylococcal Infections; Staphylococcal Toxoid; Staphylococcal Vaccines; Staphylococcus; Staphylococcus Phages; Vancomycin; Wound Infection | 1968 |
Modern management of severe staphylococcal disease.
Topics: Anti-Bacterial Agents; Carbon Dioxide; Carbon Isotopes; Cephalosporins; Cross Infection; Europe; Hospitals, Teaching; Humans; Israel; Penicillin Resistance; Penicillins; Protein Binding; Staphylococcal Infections; Staphylococcus; Time Factors; United States; Vancomycin | 1973 |
Staphylococcal resistance to antibiotics: origin, measurement, and epidemiology.
Topics: Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Coagulase; Cross Infection; Diffusion; DNA, Bacterial; Erythromycin; Extrachromosomal Inheritance; Humans; Kanamycin; Methicillin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillinase; Staphylococcal Infections; Staphylococcus; Streptomycin; Temperature; Tetracycline; Transduction, Genetic | 1974 |
53 trial(s) available for cephalosporin c and Cross Infection
Article | Year |
---|---|
Pharmacokinetics and Safety of Ceftobiprole in Pediatric Patients.
Topics: Administration, Intravenous; Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Data Analysis; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Pneumonia | 2021 |
Iron serum levels and iron homeostasis parameters in patients with nosocomial pneumonia treated with cefiderocol: post hoc analysis of the APEKS-NP study.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Cross Infection; Double-Blind Method; Healthcare-Associated Pneumonia; Homeostasis; Humans; Iron | 2022 |
The effects of topical antibiotics on eradication and acquisition of third-generation cephalosporin and carbapenem-resistant Gram-negative bacteria in ICU patients; a post hoc analysis from a multicentre cluster-randomized trial.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cohort Studies; Cross Infection; Cross-Over Studies; Drug Resistance, Bacterial; Female; Gastrointestinal Tract; Gram-Negative Bacteria; Humans; Intensive Care Units; Male; Middle Aged; Mouthwashes | 2020 |
Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Female; Humans; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Tazobactam; Treatment Outcome | 2019 |
A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients.
Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cross Infection; Female; Hospitalization; Humans; Infant; Infusions, Intravenous; Male; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2021 |
A
Topics: Asia, Eastern; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans; Pneumonia, Bacterial | 2021 |
Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Republic of Korea; Tazobactam; Urinary Tract Infections | 2017 |
Antibiotic use practice and predictors of hospital outcome among patients with systemic bacterial infection: Identifying targets for antibiotic and health care resource stewardship.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Female; Health Resources; Humans; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Vancomycin | 2019 |
Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Female; Humans; Linezolid; Male; Middle Aged; Pneumonia; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2019 |
A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia.
Topics: Acetamides; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Therapy; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Young Adult | 2014 |
[Clinical efficacy of the antimicrobial drug furamag in nosocomial urinary tract infections].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Therapy, Combination; Female; Fumarates; Humans; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections | 2014 |
Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia.
Topics: Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cephalosporins; Cross Infection; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Penicillanic Acid; Pneumonia; Tazobactam; Young Adult | 2016 |
A randomized open label study of 'imipenem vs. cefepime' in spontaneous bacterial peritonitis.
Topics: Adult; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Imipenem; India; Liver Cirrhosis; Male; Middle Aged; Paracentesis; Peritonitis; Risk Factors; Severity of Illness Index; Survival Analysis; Time Factors | 2016 |
Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Drug Combinations; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas Infections; Treatment Outcome | 2008 |
Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Cross Infection; Cross-Over Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Female; Fluoroquinolones; Gram-Negative Aerobic Bacteria; Humans; Infection Control; Intensive Care Units; Intestines; Male; Middle Aged; Netherlands; Policy Making | 2010 |
Impact of limited cephalosporin use on prevalence of methicillin-resistant Staphylococcus aureus in the intensive care unit.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Infection Control; Intensive Care Units; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Prevalence; Pseudomonas aeruginosa; Staphylococcal Infections | 2009 |
Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Teaching; Hospitals, Urban; Humans; Infusions, Intravenous; Intensive Care Units; Length of Stay; Male; Meropenem; Middle Aged; Missouri; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2013 |
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study.
Topics: Adult; Aged; APACHE; Cefepime; Cephalosporins; Cilastatin; Critical Care; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; Protease Inhibitors; Respiration, Artificial; Thienamycins | 2003 |
Pre-incisional antibiotic infiltration for prevention of surgical-site infection.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Cross Infection; Female; Humans; Incidence; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Surgical Procedures, Operative; Surgical Wound Infection | 2004 |
High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Critical Illness; Cross Infection; Drug Therapy, Combination; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Skilled Nursing Facilities | 2006 |
The impact of an intensive antimicrobial control program in a Taiwanese medical center.
Topics: Adult; Aged; Aminoglycosides; Anti-Infective Agents; Bacterial Infections; Cephalosporins; Cross Infection; Drug Costs; Drug Resistance, Bacterial; Drug Utilization Review; Economics, Hospital; Erythromycin; Female; Glycopeptides; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Quinolones; Taiwan; Tetracyclines; Time Factors; Treatment Outcome | 2006 |
Cefepime cerebrospinal fluid concentrations in neonatal bacterial meningitis.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Dominican Republic; Female; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Klebsiella pneumoniae; Male; Meningitis, Bacterial | 2007 |
Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Cross Infection; Double-Blind Method; Drug Administration Schedule; Drug Costs; Female; Humans; Injections, Intramuscular; Male; Nursing Homes; Pneumonia, Bacterial | 2007 |
Cefepime in intensive care unit patients: validation of a population pharmacokinetic approach and influence of covariables.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Creatinine; Cross Infection; France; Humans; Infusions, Intravenous; Intensive Care Units; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nonlinear Dynamics; Prospective Studies | 2008 |
[Clinical evaluation of moxalactam].
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Clinical Trials as Topic; Critical Care; Cross Infection; Humans; Meningitis; Moxalactam; Sepsis; Urinary Tract Infections | 1983 |
[Evolution of the intestinal flora in patients under preventive treatment with cephalosporins].
Topics: Administration, Oral; Adult; Aged; Cephalosporins; Coronary Artery Bypass; Cross Infection; Drug Resistance, Microbial; Enterobacter; Erythromycin; Escherichia; Escherichia coli; Feces; Female; Gentamicins; Humans; Injections, Intravenous; Klebsiella; Klebsiella pneumoniae; Male; Middle Aged; Pseudomonas; Serratia; Sulfamethoxazole; Sulfonamides; Trimethoprim | 1982 |
A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Bacterial Infections; Cefepime; Cephalosporins; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Respiratory Tract Infections; Shock, Septic | 1993 |
Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections.
Topics: Acute Disease; Analysis of Variance; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Female; Humans; Infusions, Intravenous; Male; Middle Aged; United States | 1996 |
Treatment of urinary tract infections: selecting an appropriate broad-spectrum antibiotic for nosocomial infections.
Topics: Bacteremia; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Female; Humans; Male; Middle Aged; Time Factors; United States; Urinary Tract Infections | 1996 |
Serum bactericidal activity of ceftizoxime and ceftriaxone against pathogens associated with community-acquired and nosocomial pneumonias.
Topics: Adolescent; Adult; Ceftizoxime; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Cross-Over Studies; Female; Humans; Male; Pneumonia, Bacterial; Prospective Studies; Serum Bactericidal Test | 1996 |
[Evaluation of the effectiveness of ceftazidime in treatment of nosocomial infections in children].
Topics: Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Escherichia coli Infections; Humans; Infant; Pneumonia; Urinary Tract Infections | 1996 |
[Cefpirome--a fourth generation antibiotic for the treatment of severe hospital infections].
Topics: Adult; Cefpirome; Cephalosporins; Cross Infection; Hospitals, Municipal; Humans; Microbial Sensitivity Tests; Russia; Treatment Outcome | 1996 |
Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma.
Topics: Adult; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Coma; Cross Infection; Female; Humans; Infusions, Intravenous; Male; Multivariate Analysis; Pneumonia, Bacterial; Prospective Studies; Respiration, Artificial; Risk Factors | 1997 |
Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Prospective Studies; Respiratory Tract Infections; Thienamycins; Time Factors; Tobramycin | 1997 |
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.
Topics: Adult; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Utilization Review; Guideline Adherence; Hospital Bed Capacity, 500 and over; Hospitals, Community; Humans; Imipenem; Incidence; Infection Control; Klebsiella; Klebsiella Infections; New York City; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1998 |
Outbreaks of Staphylococcus aureus infections during treatment of late onset pneumonia with ciprofloxacin in a prospective, randomized study.
Topics: Adult; Anti-Infective Agents; APACHE; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Intensive Care Units; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Superinfection | 1998 |
[Phare study. Comparative study of combined cefepime-amikacin versus ceftazidime combined with amikacin in the treatment of nosocomial pneumonias in ventilated patients. Multicenter group study].
Topics: Amikacin; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Survival Rate | 1999 |
A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ceftriaxone; Cephalosporins; Chi-Square Distribution; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Pancreas Transplantation; Postoperative Complications; Risk Factors; Statistics, Nonparametric; Treatment Outcome; Vancomycin | 1999 |
[The results of a multicenter study of the comparative activity of cefepime and other antibiotics against the causative agents of severe hospital infections (the Micromax program)].
Topics: Acute Disease; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Russia | 1999 |
Association between cephalosporin therapy and subsequent nosocomial enterococcal colonization in surgical patients.
Topics: Adult; Antibiotic Prophylaxis; Cephalosporins; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Retrospective Studies; Risk Factors | 1999 |
Intermittent and continuous ceftazidime infusion for critically ill trauma patients.
Topics: Adolescent; Adult; Aged; Ceftazidime; Cephalosporins; Chi-Square Distribution; Critical Illness; Cross Infection; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Probability; Treatment Outcome; Wounds and Injuries | 2000 |
Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Cost-Benefit Analysis; Cross Infection; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia; Prospective Studies; Treatment Outcome | 2001 |
Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
Topics: Aged; Amikacin; Ceftazidime; Cephalosporins; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Hospital Mortality; Hospitals, Teaching; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Proportional Hazards Models; Prospective Studies; Spain; Survival Analysis; Treatment Outcome | 2001 |
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Critical Care; Cross Infection; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Safety; Tobramycin | 2001 |
A prospective, randomized, multicenter comparative study of clinafloxacin versus a ceftriaxone-based regimen in the treatment of hospitalized patients with community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2001 |
Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Cytokines; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Statistics, Nonparametric; Thienamycins; Tumor Necrosis Factor-alpha | 2002 |
A study of the etiologies and treatment of nosocomial pneumonia in a community-based teaching hospital.
Topics: Adult; Aged; Aged, 80 and over; Cephalosporins; Cross Infection; Female; Haemophilus Infections; Haemophilus influenzae; Hospital Bed Capacity, 100 to 299; Hospitals, Community; Hospitals, Teaching; Hospitals, Veterans; Humans; Male; Middle Aged; Pneumococcal Infections; Pneumonia; Retrospective Studies; Single-Blind Method; Virginia | 1992 |
Prospective randomized phase II study of intravenous cefpirome 1g or 2g bd in the treatment of hospitalized patients with different infections. Cefpirome Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefpirome; Cephalosporins; Cross Infection; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies | 1992 |
Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intensive Care Units; Intestines; Klebsiella pneumoniae; Middle Aged; Nalidixic Acid; Neomycin; Paris; Random Allocation; Risk Factors | 1989 |
Antibiotic prophylaxis in open-heart surgery: a comparison of cefamandole, cefuroxime, and cefazolin.
Topics: Cardiac Surgical Procedures; Cefamandole; Cefazolin; Cefuroxime; Cephalosporins; Cross Infection; Female; Humans; Male; Middle Aged; Premedication; Prospective Studies; Random Allocation; Risk Factors; Surgical Wound Infection | 1988 |
Third generation cephalosporin antibiotics in surgical practice.
Topics: Bacteria; Bacterial Infections; Central Nervous System Diseases; Cephalosporins; Chemical Phenomena; Chemistry; Cholecystitis; Clinical Trials as Topic; Cross Infection; Female; Genital Diseases, Female; Humans; Premedication; Surgical Wound Infection | 1986 |
Cephaloridine clinical trial in gram-positive and gram-negative infections.
Topics: Cephaloridine; Cephalosporins; Cross Infection; Female; Humans; In Vitro Techniques; Male; Respiratory Tract Infections; Urinary Tract Infections | 1966 |
490 other study(ies) available for cephalosporin c and Cross Infection
Article | Year |
---|---|
Recommendations for antibiotic selection for severe nosocomial infections.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Humans; Tazobactam | 2021 |
Population Dynamics of Escherichia coli Causing Bloodstream Infections over Extended Time Periods.
Topics: Anti-Bacterial Agents; Bacteremia; Canada; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; England; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Humans; Population Dynamics | 2021 |
Correlation between antibiotic consumption and the occurrence of multidrug-resistant organisms in a Malaysian tertiary hospital: a 3-year observational study.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Inappropriate Prescribing; Klebsiella; Klebsiella Infections; Malaysia; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Tertiary Care Centers | 2022 |
Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji.
Topics: Bacteremia; Cephalosporins; Cross Infection; Fiji; Humans; Length of Stay; Prospective Studies | 2022 |
Epidemiologic Correlation and Drug Resistance Analysis of Pathogenic Bacteria in Different Open Limb Injury External Conditions.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Extremities; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies | 2022 |
HEALTHCARE-ASSOCIATED TUBO-OVARIAN INFECTIONS IN UKRAINE: RESULTS OF A MULTICENTER STUDY (2020-2022).
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cohort Studies; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Methicillin; Pseudomonas aeruginosa; Staphylococcus aureus; Ukraine; Vancomycin | 2022 |
Epidemiology and infection control of Methicillin-resistant Staphylococcus aureus in a German tertiary neonatal intensive and intermediate care unit: A retrospective study (2013-2020).
Topics: Cefotaxime; Cephalosporins; Cross Infection; Humans; Infant; Infant, Newborn; Infection Control; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Retrospective Studies; Staphylococcal Infections | 2022 |
Transfer of Extended Spectrum Cephalosporin Resistant Enterobacteriaceae Among Patients on an HSCT Unit and the Value of Surveillance and Contact Isolation.
Topics: beta-Lactamases; Cephalosporins; Cross Infection; Enterobacteriaceae; Escherichia coli; Hematopoietic Stem Cell Transplantation; Humans; Monobactams; Retrospective Studies | 2023 |
Efficacy predictors of third-generation cephalosporins in treating spontaneous bacterial peritonitis.
Topics: Anti-Bacterial Agents; Ascites; Ascitic Fluid; Bacterial Infections; Cephalosporins; Cross Infection; Humans; Liver Cirrhosis; Peritonitis; Retrospective Studies | 2022 |
CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE - a multi-centre experience in Italy.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Humans; Italy; Male; Middle Aged; Pneumonia; Retrospective Studies; Sepsis | 2023 |
Investigating Possible Interspecies Communication of Plasmids Associated with Transfer of Third-Generation Cephalosporin, Quinolone, and Colistin Resistance Between Simultaneously Isolated Escherichia Coli and Klebsiella Pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Coinfection; Colistin; Communication; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Quinolones | 2023 |
Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey.
Topics: Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Cross Infection; Drug Resistance, Multiple, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; O Antigens; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections; Public Health Surveillance; Serogroup; Serotyping; Spain; Tazobactam; Whole Genome Sequencing | 2019 |
Econometric ARIMA methodology to elucidate the evolution of trends in nosocomial antimicrobial resistance rates in the European Union.
Topics: Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Europe; European Union; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Models, Econometric; Models, Theoretical; Pseudomonas aeruginosa; Pseudomonas Infections | 2020 |
Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diabetes Mellitus; Diarrhea; Female; Hospitalization; Humans; Logistic Models; Male; Middle Aged; Neoplasms; Odds Ratio; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Taiwan | 2021 |
Direct medical costs of urinary tract infections by Gram-negative bacilli resistant to beta-lactams in a tertiary care hospital in Medellín, Colombia
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cephalosporins; Cohort Studies; Colombia; Cross Infection; Diagnostic Imaging; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Health Expenditures; Hospitalization; Hospitals, Urban; Humans; Male; Middle Aged; Tertiary Care Centers; Urinary Tract Infections | 2019 |
Can ceftolozane-tazobactam treat nosocomial pneumonia?
Topics: Cephalosporins; Cross Infection; Double-Blind Method; Humans; Meropenem; Pneumonia; Tazobactam | 2019 |
Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cephalosporins; Cross Infection; DNA, Bacterial; Humans; Italy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Pneumonia, Bacterial; Prevalence; Public Health Surveillance; Staphylococcal Infections; Staphylococcus aureus; Virulence; Whole Genome Sequencing | 2019 |
Piperacillin-tazobactam should be preferred to third-generation cephalosporins to treat wild-type inducible AmpC-producing Enterobacterales in critically ill patients with hospital or ventilator-acquired pneumonia.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Critical Illness; Cross Infection; Enterobacter; Family Characteristics; Female; Hospitals; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Penicillanic Acid; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Retrospective Studies; Ventilators, Mechanical | 2020 |
Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia - Authors' reply.
Topics: Cephalosporins; Cross Infection; Doripenem; Double-Blind Method; Humans; Meropenem; Pneumonia, Ventilator-Associated; Tazobactam | 2020 |
Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia.
Topics: Cephalosporins; Cross Infection; Doripenem; Double-Blind Method; Humans; Meropenem; Pneumonia, Ventilator-Associated; Tazobactam | 2020 |
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Healthcare-Associated Pneumonia; Humans; Pharmaceutical Preparations; Polymyxins; Pseudomonas aeruginosa; Tazobactam; Treatment Outcome | 2020 |
Healthcare associated
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Delivery of Health Care; Drug Therapy; Female; Fluoroquinolones; Hospital Mortality; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Serbia; Tertiary Care Centers | 2020 |
In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum β-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitalized patients (SMART 2016).
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tazobactam | 2020 |
Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
Topics: Adaptation, Physiological; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cephalosporins; Clindamycin; Clostridioides difficile; Clostridium Infections; Cross Infection; Daptomycin; Doxycycline; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Retrospective Studies | 2020 |
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Germany; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2020 |
Prescriber perceptions of fluoroquinolones, extended-spectrum cephalosporins, and
Topics: Anti-Bacterial Agents; Cephalosporins; Clostridioides; Clostridioides difficile; Clostridium Infections; Cross Infection; Fluoroquinolones; Humans; Perception | 2020 |
An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Humans; Prospective Studies; Sepsis | 2021 |
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against European Gram-negative bacterial surveillance isolates collected during 2012-18.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Europe; Europe, Eastern; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2020 |
Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Critical Illness; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Spain; Tazobactam; Treatment Outcome | 2021 |
Are third-generation cephalosporins still an option for empirical antibiotic therapy in critically ill trauma patients with early ventilator or hospital-acquired pneumonia?
Topics: Anti-Bacterial Agents; Cephalosporins; Critical Illness; Cross Infection; Hospitals; Humans; Pneumonia; Ventilators, Mechanical | 2021 |
Mortality associated with third generation cephalosporin-resistance in Enterobacteriaceae infections: a multicenter cohort study in Southern China.
Topics: Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Cohort Studies; Cross Infection; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged | 2021 |
Real-life experience in the use of ceftobiprole for the treatment of nosocomial pneumonia: a case series.
Topics: Cephalosporins; Cross Infection; Healthcare-Associated Pneumonia; Humans | 2021 |
Expansion of highly stable bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Host Specificity; Humans; India; Integrons; Male; Microbial Sensitivity Tests; Multigene Family; Species Specificity; Tertiary Care Centers | 2017 |
Characterizing non-linear effects of hospitalisation duration on antimicrobial resistance in respiratory isolates: an analysis of a prospective nationwide surveillance system.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacter; Escherichia coli; Female; Hospitalization; Humans; Klebsiella pneumoniae; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Pneumonia; Pseudomonas aeruginosa; Respiratory System; Retrospective Studies; Staphylococcus aureus; Streptococcus pneumoniae | 2018 |
Impact of broad-spectrum antimicrobial treatment on the ecology of intestinal flora.
Topics: Acinetobacter baumannii; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Feces; Female; Fluoroquinolones; Gastrointestinal Microbiome; Humans; Male; Microbial Viability; Middle Aged; Moxifloxacin; Pseudomonas aeruginosa; Taiwan | 2018 |
Multicenter Evaluation of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Inhibitory Activity against Meropenem-Nonsusceptible Pseudomonas aeruginosa from Blood, Respiratory Tract, and Wounds.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Catheter-Related Infections; Ceftazidime; Cephalosporins; Cross Infection; Drug Combinations; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins | 2017 |
Acinetobacter baumannii isolated from hospital-acquired infection: biofilm production and drug susceptibility.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aminoglycosides; Anti-Bacterial Agents; Biofilms; Cephalosporins; Cross Infection; Culture Media; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Plankton; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
The Transmissibility of Antibiotic-Resistant Enterobacteriaceae in Intensive Care Units.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Intensive Care Units; Klebsiella Infections; Longitudinal Studies; Microbial Sensitivity Tests; Models, Theoretical; Prospective Studies | 2018 |
Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.
Topics: Aged; Aged, 80 and over; Carbapenems; Cephalosporins; Cohort Studies; Critical Illness; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Rectum | 2017 |
Determination of alternative ceftolozane/tazobactam dosing regimens for patients with infections due to Pseudomonas aeruginosa with MIC values between 4 and 32 mg/L.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Combinations; Female; Humans; Infusions, Intravenous; Kidney Function Tests; Male; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2017 |
Patient age as a factor of antibiotic resistance in methicillin-resistant Staphylococcus aureus.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; Young Adult | 2017 |
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Humans; Italy; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Whole Genome Sequencing | 2018 |
In vitro activity of ceftolozane/tazobactam versus antimicrobial non-susceptible Pseudomonas aeruginosa clinical isolates including MDR and XDR isolates obtained from across Canada as part of the CANWARD study, 2008-16.
Topics: Canada; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2018 |
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Catheter-Related Infections; Cephalosporins; China; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Factors | 2018 |
Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; France; Glycopeptides; Guidelines as Topic; Hospitals; Humans; Intensive Care Units; Logistic Models; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Prescriptions; Probability; Retrospective Studies | 2018 |
High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Fluoroquinolones; Germany; Hospitalization; Hospitals, University; Humans; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies | 2018 |
Community-acquired Clostridium difficile infection in Serbian pediatric population.
Topics: Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Diarrhea; Female; Humans; Infant; Male; Penicillins; Prospective Studies; Retrospective Studies; Risk Factors; Serbia | 2018 |
Acinetobacter baumannii Resistance Trends in Children in the United States, 1999-2012.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Infection; Databases, Factual; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Logistic Models; Male; Microbial Sensitivity Tests; Prevalence; Regression Analysis; United States | 2019 |
Development of diagnostic prediction tools for bacteraemia caused by third-generation cephalosporin-resistant enterobacteria in suspected bacterial infections: a nested case-control study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors | 2018 |
ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Child; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; South Africa | 2018 |
Whole-Genome Analysis of an Extensively Drug-Resistance Empedobacter falsenii Strain Reveals Distinct Features and the Presence of a Novel Metallo-ß-Lactamase (EBR-2).
Topics: Amino Acid Sequence; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae; Genome, Bacterial; Humans; Meropenem; Microbial Sensitivity Tests; Penicillin G; Thienamycins | 2018 |
Ceftolozane/tazobactam sensitivity patterns in Pseudomonas aeruginosa isolates recovered from sputum of cystic fibrosis patients.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tazobactam | 2018 |
[Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015]
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Cross Infection; Drug Resistance; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Thienamycins | 2016 |
Activity of Ceftolozane-Tazobactam against
Topics: Anti-Bacterial Agents; Burkholderia pseudomallei; Cephalosporins; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Humans; Melioidosis; Microbial Sensitivity Tests; Tazobactam | 2018 |
Extended-spectrum β-lactamase-producing E. coli septicemia among rectal carriers in the ICU.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Cephalosporins; China; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Hospitals; Humans; Intensive Care Units; Male; Middle Aged; Rectal Diseases; Retrospective Studies; Risk Factors | 2018 |
Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; India; Inpatients; Intensive Care Units; Male; Middle Aged; Prospective Studies; Young Adult | 2018 |
Clostridioides difficile incidence related to in-hospital cephalosporin use: a tale of two highly comparable hospitals.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Scandinavian and Nordic Countries | 2019 |
Antimicrobial activity of ceftolozane-tazobactam against multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa clinical isolates from a Spanish hospital.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam | 2019 |
Alarming levels of antimicrobial resistance among sepsis patients admitted to ICU in a tertiary care hospital in India - a case control retrospective study.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Case-Control Studies; Cephalosporins; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Genetic Variation; HeLa Cells; Hospitalization; Humans; India; Intensive Care Units; Polymerase Chain Reaction; Prevalence; Retrospective Studies; Sepsis; Tertiary Care Centers | 2018 |
Identification of
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression; Genes, Bacterial; Hospitals; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Macrolides; Microbial Sensitivity Tests; Penicillins; Tetracyclines; Whole Genome Sequencing | 2019 |
Incidence of infections due to third generation cephalosporin-resistant
Topics: Aged; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Germany; Hospitals, University; Humans; Incidence; Male; Middle Aged; Patient Admission; Prospective Studies | 2018 |
Activity of Ceftolozane/Tazobactam Against Gram-Negative Rods of the Family Enterobacteriaceae and Pseudomonas Spp. Isolated from Onco-Hematological Patients Hospitalized in a Clinical Hospital in Poland.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Hospitals; Humans; Microbial Sensitivity Tests; Patients; Poland; Pseudomonas; Pseudomonas Infections; Tazobactam | 2019 |
Epidemiology and risk factors for multi-drug resistant hospital-acquired urinary tract infection in patients with liver cirrhosis: single center experience in Serbia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; Female; Humans; Klebsiella; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Risk Factors; Serbia; Urinary Tract Infections | 2019 |
Association Between Antibiotic Use and Hospital-onset Clostridioides difficile Infection in US Acute Care Hospitals, 2006-2012: An Ecologic Analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Cross-Sectional Studies; Drug Prescriptions; Ecological and Environmental Phenomena; Female; Fluoroquinolones; Hospitalization; Hospitals; Humans; Interrupted Time Series Analysis; Male; Metronidazole; Middle Aged; United States; Vancomycin | 2020 |
A Combination Antibiogram Evaluation for
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; United States | 2019 |
Distribution of
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Cross Infection; Cross-Sectional Studies; Escherichia coli Proteins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Pakistan; Plasmids; Tertiary Care Centers; Young Adult | 2019 |
Carbapenem and Cephalosporin Resistance among Enterobacteriaceae in Healthcare-Associated Infections, California, USA
Topics: beta-Lactam Resistance; California; Carbapenems; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Geography, Medical; Humans; Microbial Sensitivity Tests | 2019 |
Antimicrobial consumption in three pediatric and neonatal intensive care units in Saudi Arabia: 33-month surveillance study.
Topics: Adolescent; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Infection; Epidemiological Monitoring; Female; Humans; Infant; Intensive Care Units, Neonatal; Male; Pediatrics; Prospective Studies; Saudi Arabia; Vancomycin | 2019 |
Studies of selective digestive decontamination as a natural experiment to evaluate topical antibiotic prophylaxis and cephalosporin use as population-level risk factors for enterococcal bacteraemia among ICU patients.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Cross Infection; Decontamination; Enterococcus; Gastrointestinal Tract; Humans; Incidence; Intensive Care Units; Oropharynx; Respiration, Artificial; Risk Factors | 2019 |
Local outbreak of extended-spectrum β-lactamase SHV2a-producing Pseudomonas aeruginosa reveals the emergence of a new specific sub-lineage of the international ST235 high-risk clone.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cross Infection; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; France; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymorphism, Single Nucleotide; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2020 |
Monte Carlo simulations based on phase 1 studies predict target attainment of ceftobiprole in nosocomial pneumonia patients: a validation study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Cross Infection; Drug Dosage Calculations; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Pneumonia, Bacterial | 2013 |
Repeated colonization by multi-drug-resistant Acinetobacter calcoaceticus-A. baumannii complex and changes in antimicrobial susceptibilities in surgical intensive care units.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Cefepime; Cephalosporins; Chi-Square Distribution; China; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Public Health Surveillance; Retrospective Studies | 2013 |
Faecal carriage of oxyiminocephalosporin-resistant Enterobacteriaceae among paediatric units in different hospitals in the south of France.
Topics: Adolescent; Anti-Bacterial Agents; Carrier State; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; France; Genes, Bacterial; Hospitals; Humans; Infant; Male; Prospective Studies | 2013 |
Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pneumonia; Retrospective Studies; Risk Factors | 2013 |
Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Clostridioides difficile; Coronary Artery Bypass; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Propensity Score; Proportional Hazards Models; Risk Assessment; Risk Factors; Surgical Wound Infection; Time Factors; Treatment Outcome; United States; Vancomycin | 2013 |
Impact of an enhanced antibiotic stewardship on reducing methicillin-resistant Staphylococcus aureus in primary and secondary healthcare settings.
Topics: Anti-Bacterial Agents; Cephalosporins; Clindamycin; Cross Infection; Drug Utilization; Fluoroquinolones; Humans; Incidence; Methicillin-Resistant Staphylococcus aureus; Northern Ireland; Primary Health Care; Retrospective Studies; Staphylococcal Infections | 2014 |
Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended-spectrum β-lactamases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Environmental Microbiology; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Sweden; Virulence | 2014 |
Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland.
Topics: Ambulatory Care Facilities; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Chromosomes; Cluster Analysis; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Hospitals; Humans; Microarray Analysis; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Switzerland | 2013 |
Cefepime-induced nonconvulsive status epilepticus as a cause of confusion in an elderly patient.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Confusion; Cross Infection; Electroencephalography; Humans; Male; Status Epilepticus | 2015 |
In vitro activity of ceftolozane-tazobactam against Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals in the CANWARD study, 2007 to 2012.
Topics: Anti-Bacterial Agents; Canada; Ceftazidime; Cephalosporins; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam | 2013 |
In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Canada; Ceftaroline; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Public Health Surveillance; Retrospective Studies | 2013 |
Third-generation cephalosporin-resistant spontaneous bacterial peritonitis: a single-centre experience and summary of existing studies.
Topics: Anti-Bacterial Agents; Bacterial Infections; Canada; Cephalosporin Resistance; Cephalosporins; Cohort Studies; Community-Acquired Infections; Cross Infection; Female; Humans; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Peritonitis; Prevalence; Retrospective Studies | 2014 |
Risk factors for hospital-acquired bloodstream infections caused by extended-spectrum β-lactamase Klebsiella pneumoniae among cancer patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Case-Control Studies; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasms; Prevalence; Retrospective Studies; Risk Factors | 2014 |
Activity of ceftaroline against community associated and healthcare associated methicillin resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2014 |
Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Cross Infection; Daptomycin; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Models, Biological; Monte Carlo Method; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2014 |
Characterization of KPC-2-producing Escherichia coli, Citrobacter freundii, Enterobacter cloacae, Enterobacter aerogenes, and Klebsiella oxytoca isolates from a Chinese Hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; China; Cross Infection; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Hospitals; Humans; Methyltransferases; Microbial Sensitivity Tests; Plasmids; Survival Analysis | 2014 |
Which antibiotic for hospital acquired pneumonia caused by MRSA?
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin | 2014 |
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies | 2015 |
Of stewardship, motherhood and apple pie.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clostridioides difficile; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Penicillins; Selection, Genetic | 2014 |
[Ceftaroline fosamil in community-acquired and nosocomial pneumonia].
Topics: Animals; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Streptococcus pneumoniae | 2014 |
Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Utilization; Drug Utilization Review; Fluoroquinolones; Humans; Incidence; Tertiary Healthcare | 2014 |
Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Citrobacter; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacter; Escherichia coli; Europe; Gram-Negative Aerobic Bacteria; Humans; Intraabdominal Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Proteus mirabilis; Pseudomonas aeruginosa; Serratia; Tazobactam; United States; Urinary Tract Infections | 2014 |
Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Catchment Area, Health; Cephalosporins; Cohort Studies; Comorbidity; Cross Infection; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Hospitalization; Hospitals, Teaching; Hospitals, Urban; Humans; Institutionalization; Long-Term Care; Middle Aged; Nalidixic Acid; Ofloxacin; Pyelonephritis; Retrospective Studies; Risk Factors | 2014 |
Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012).
Topics: Academic Medical Centers; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pneumonia, Bacterial; Tazobactam; United States | 2014 |
Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12).
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Genotype; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2014 |
[Antibiotic stewardship has been established at Herlev Hospital].
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Cephalosporins; Clostridium Infections; Cross Infection; Drug Prescriptions; Drug Utilization Review; Hospitals; Humans; Medical Audit; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinolones | 2014 |
Clinical manifestations and prognostic factors of Morganella morganii bacteremia.
Topics: Age Factors; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Morganella morganii; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Taiwan | 2015 |
Mutation-driven β-lactam resistance mechanisms among contemporary ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitals.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Gene Expression Regulation, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Porins; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2014 |
Detection of PEr 1 extended-spectrum β-lactamase among nosocomial providencia stuartii isolates in Tunisia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Hospitals, Military; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Providencia; Tunisia | 2014 |
Implementing an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a 200-bed community hospital in Germany.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Germany; Hospitals, Community; Humans; Incidence; Interrupted Time Series Analysis; Pharmacy Service, Hospital; Prescriptions | 2015 |
Factors associated with Clostridium difficile diarrhea in a hospital in Beijing, China.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cephalosporins; China; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Glycopeptides; Humans; Incidence; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Statistics, Nonparametric | 2014 |
[Antimicrobial properties of ceftaroline fosamil].
Topics: Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2014 |
[Zinforo™ (ceftaroline fosamil)--A new beta-lactam-cephalosporin with MRSA activity].
Topics: Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Staphylococcal Infections | 2014 |
Efficacy of anti-pseudomonal antibiotics: need to reconsider the empirical use of cefepime.
Topics: Aged; Aged, 80 and over; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Epidemiology and microbiology of nosocomial bloodstream infections: analysis of 482 cases from a retrospective surveillance study.
Topics: Acinetobacter; Adult; Aged; Aged, 80 and over; Bacteremia; Cephalosporins; China; Coagulase; Cross Infection; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Medicine, Chinese Traditional; Microbial Sensitivity Tests; Middle Aged; Regression Analysis; Retrospective Studies; Risk Factors; Shock, Septic; Staphylococcus; Treatment Outcome | 2015 |
Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ceftaroline; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation, Missense; Penicillin-Binding Proteins; Staphylococcal Infections; Switzerland | 2015 |
Flomoxef showed excellent in vitro activity against clinically important gram-positive and gram-negative pathogens causing community- and hospital-associated infections.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals, University; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2015 |
A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: susceptibility to ceftaroline and molecular epidemiology.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; China; Cities; Cross Infection; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Staphylococcal Skin Infections; Virulence Factors | 2015 |
Turning the tide or riding the waves? Impacts of antibiotic stewardship and infection control on MRSA strain dynamics in a Scottish region over 16 years: non-linear time series analysis.
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; Cephalosporins; Cross Infection; Drug Resistance; Hand Hygiene; Humans; Infection Control; Length of Stay; Macrolides; Mass Screening; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Prevalence; Retrospective Studies; Scotland; Species Specificity; Staphylococcal Infections | 2015 |
Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental study.
Topics: Anti-Bacterial Agents; Carrier State; Cephalosporin Resistance; Cephalosporins; Cross Infection; Enterobacteriaceae; Humans; Incidence; Infection Control; Intensive Care Units; Mass Screening; Rectum | 2015 |
Different duration strategies of perioperative antibiotic prophylaxis in adult patients undergoing cardiac surgery: an observational study.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Cephalosporins; Cross Infection; Female; Humans; Male; Middle Aged; Perioperative Care; Postoperative Complications; Retrospective Studies; Surgical Wound Infection | 2015 |
Non-susceptibility to ceftaroline in healthcare-associated multiresistant MRSA in Eastern Australia.
Topics: Anti-Bacterial Agents; Australia; Ceftaroline; Cephalosporin Resistance; Cephalosporins; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prospective Studies; Staphylococcal Infections | 2015 |
Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Feces; Female; Hospitalization; Hospitals; Humans; Logistic Models; Male; Prospective Studies; Ribotyping; Risk Factors | 2015 |
Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Critical Care; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pilot Projects; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies | 2015 |
Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals.
Topics: Adult; Anti-Infective Agents; beta-Lactamases; Cefepime; Cephalosporins; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; United States | 2015 |
Pathogens of skin and skin-structure infections in the UK and their susceptibility to antibiotics, including ceftaroline.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Skin Diseases, Bacterial; United Kingdom; Young Adult | 2015 |
Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Utilization; Female; Fluoroquinolones; Humans; Infection Control; Interrupted Time Series Analysis; Male; Ribotyping | 2015 |
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cephalosporins; Ciprofloxacin; Cross Infection; Female; Hospitals; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Taiwan; Thienamycins | 2017 |
Could ceftaroline be an alternative therapy for linezolid resistant Staphylococcus epidermidis infections in Intensive Care Medicine?
Topics: Anti-Bacterial Agents; Bacteremia; Body Fluids; Catheter-Related Infections; Ceftaroline; Cephalosporins; Critical Care; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Humans; Linezolid; Methicillin; Minocycline; Staphylococcal Infections; Staphylococcus epidermidis; Tigecycline; Vancomycin | 2015 |
Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole.
Topics: Anti-Bacterial Agents; Asia; Bacterial Toxins; Cephalosporins; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Cross Infection; Europe; Exotoxins; Genotype; Humans; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; North America; Pneumonia; South Africa; South America; Staphylococcal Infections | 2016 |
Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study.
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Communicable Disease Control; Community-Acquired Infections; Cross Infection; Drug Utilization; Female; Hand Hygiene; Humans; Macrolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prevalence; Retrospective Studies; Scotland; Staphylococcal Infections | 2015 |
Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Finland; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Prospective Studies | 2016 |
Investigation of a cluster of Clostridium difficile infections in a pediatric oncology setting.
Topics: Adolescent; Anti-Bacterial Agents; Case-Control Studies; Cefepime; Cephalosporins; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross Infection; Feces; Female; Hospitalization; Hospitals; Humans; Infant; Infection Control; Male; Medical Oncology; Pediatrics; Risk Factors; Young Adult | 2016 |
Ceftaroline activity tested against viridans group streptococci from US hospitals.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Humans; Microbial Sensitivity Tests; Streptococcal Infections; United States; Viridans Streptococci | 2016 |
[Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; China; Cross Infection; Hospitals, Teaching; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline; Vancomycin | 2015 |
Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitals.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcal Infections; Staphylococcus; United States | 2016 |
Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
Topics: Aged; Anti-Bacterial Agents; Bile Acids and Salts; Cephalosporins; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Eubacterium; Female; Fluoroquinolones; Gastrointestinal Microbiome; Humans; Laxatives; Male; Metagenome; Middle Aged; Prospective Studies | 2016 |
Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.
Topics: Aged; Anti-Bacterial Agents; Canada; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Fluoroquinolones; Humans; Injections, Intravenous; Medical Audit; Middle Aged; Patients' Rooms; Regression Analysis; Risk Factors; Risk Management | 2016 |
Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Gene Expression; Gene Transfer, Horizontal; Greece; Humans; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Plasmids; Providencia; Quinolones; Replicon; Survival Analysis | 2016 |
Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014).
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Community-Acquired Infections; Cross Infection; Epidemiological Monitoring; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcal Skin Infections; United States | 2016 |
Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carrier State; Case-Control Studies; Cephalosporins; Cross Infection; Enterobacteriaceae Infections; Feces; Female; Humans; Israel; Logistic Models; Male; Middle Aged; Respiration, Artificial; Risk Factors; Tertiary Care Centers | 2016 |
Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Catchment Area, Health; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Population Surveillance; Spain; Young Adult | 2017 |
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam | 2016 |
Klebsiella pneumoniae bloodstream infections at a South African children's hospital 2006-2011, a cross-sectional study.
Topics: Bacteremia; beta-Lactamases; Cephalosporins; Child, Preschool; Community-Acquired Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; HIV Infections; Hospitals, Pediatric; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Retrospective Studies; Risk Factors; South Africa | 2016 |
Nosocomial spread of Klebsiella pneumoniae isolates producing bla
Topics: Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Plasmids | 2017 |
Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Utilization; Fluoroquinolones; Hand Hygiene; Hospitals; Humans; Infection Control; Middle Aged; Prevalence; Scotland | 2017 |
Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Cross Infection; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Gene Expression; Hospitals, Teaching; Humans; Isoenzymes; Malaysia; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Plasmids; Sequence Analysis, DNA | 2017 |
Clostridium difficile in an Urban, University-Affiliated Long-Term Acute-Care Hospital.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals, Urban; Humans; Incidence; Length of Stay; Male; Middle Aged; Multivariate Analysis; Patient Readmission; Pennsylvania; Regression Analysis; Retrospective Studies; Risk Factors | 2017 |
Analysis of the third- and fourth-generation cephalosporin use for the treatment of infections caused by Gram-negative bacteria in hospital settings.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Serbia | 2016 |
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15).
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Europe; Humans; Intraabdominal Infections; Israel; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Turkey; Urinary Tract Infections | 2017 |
Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Gene Expression; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcal Infections; Vancomycin | 2017 |
Broad-spectrum antibiotics in Norwegian hospitals.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization Review; Guideline Adherence; Hospitals; Humans; Norway; Piperacillin; Quinolones; Respiratory Tract Infections | 2017 |
Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients.
Topics: Adult; Cephalosporins; Critical Illness; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Genes, Viral; Genotype; Humans; Intensive Care Units; Male; Pharynx; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Rectum; Respiratory Mucosa | 2009 |
Decrease of methicillin resistant Staphylococcus aureus prevalence after introduction of a surgical antibiotic prophylaxis protocol in an Italian hospital.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Cross Infection; Hospitals; Humans; Infection Control; Italy; Methicillin-Resistant Staphylococcus aureus; Prevalence; Staphylococcal Infections; Surgical Wound Infection | 2008 |
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Fosfomycin; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Outpatients; Urinary Tract Infections | 2009 |
[Surveillance of multidrug resistant bacteria in a Tunisian hospital].
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Burns; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Hospitals, Urban; Humans; Imipenem; Microbial Sensitivity Tests; Practice Guidelines as Topic; Pseudomonas aeruginosa; Retrospective Studies; Sentinel Surveillance; Staphylococcus aureus; Tunisia | 2008 |
Risk factors related to a hospital-associated cluster of Clostridium difficile PCR ribotype 027 infections in Germany During 2007.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Fluoroquinolones; Germany; Hospitals, Teaching; Humans; Male; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Ribotyping; Risk Factors | 2009 |
Surveillance of intrahospital infections at the clinic for gynaecology and obstetrics.
Topics: Anti-Bacterial Agents; Bosnia and Herzegovina; Cefepime; Cephalosporins; Cross Infection; Female; Humans; Imipenem; Klebsiella pneumoniae; Obstetrics and Gynecology Department, Hospital; Population Surveillance; Prevalence; Prospective Studies; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus; Surgical Wound Infection; Urinary Tract Infections; Vancomycin | 2009 |
Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model
Topics: Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Drug Utilization; Female; Gene Expression; Genes, Bacterial; Hospitals; Humans; Integrons; Intensive Care Units; Male; Membrane Transport Proteins; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; Spain | 2009 |
[Prophylaxis and treatment of modified BFM-90 regimen for lymphoblastic lymphoma in children and adolescents accompanied with infection].
Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Cross Infection; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Female; Humans; Itraconazole; Male; Mercaptopurine; Methotrexate; Mouth Diseases; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Respiratory Tract Infections; Vincristine | 2009 |
Antimicrobial pressure and the emergence and spread of multiresistant enterococci.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Risk Factors; United States; Vancomycin Resistance | 2001 |
[Clinical characteristics and changing epidemiology of Clostridium difficile-associated disease (CDAD)].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Cephalosporins; Clostridioides difficile; Community-Acquired Infections; Cross Infection; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Male; Metronidazole; Middle Aged; Quinolones; Retrospective Studies | 2009 |
First isolation of a VIM-producing Klebsiella pneumoniae from a seven-year-old child in Venezuela.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Quinolones; Thienamycins; Urine; Venezuela | 2008 |
In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cross Infection; Gram-Negative Aerobic Bacteria; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 1981 |
Comparative in-vitro activity of ceftazidime (GR-20263) and other beta-lactamase stable cephalosporins against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamases; Ceftazidime; Cephalosporins; Cross Infection; Culture Media; Humans; Microbial Sensitivity Tests | 1981 |
In-vitro activity of ceftazidime compared with other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cross Infection; Gram-Negative Aerobic Bacteria; Gram-Negative Bacteria; Microbial Sensitivity Tests | 1981 |
Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Doxycycline; Drug Utilization; Health Services Research; Hospitals; Humans; Infection Control; Organizational Policy; Prevalence; Quinolones | 2010 |
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
In vitro potency of CXA-101, a novel cephalosporin, against Pseudomonas aeruginosa displaying various resistance phenotypes, including multidrug resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Infant; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Tazobactam; Young Adult | 2010 |
Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Multivariate Analysis; Neutropenia; Odds Ratio; Risk Factors; Severity of Illness Index; Treatment Outcome | 2010 |
In vitro bactericidal activity of ceftobiprole against hospital- and community-associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cephalosporins; Colony Count, Microbial; Community-Acquired Infections; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Staphylococcal Infections | 2010 |
Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Humans; Intensive Care Units; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
[Change of ESBLs-KPN and ESBLs-ECO after antimicrobial intervention].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged | 2010 |
In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
Topics: Acetamides; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Tobramycin; Vancomycin | 2010 |
Prospective monitoring of cefepime in intensive care unit adult patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Europe; Female; Humans; Intensive Care Units; Male; Middle Aged; Monitoring, Physiologic; Pneumonia; Prospective Studies; Young Adult | 2010 |
Drug susceptibility and clonality of methicillin-resistant Staphylococcus epidermidis in hospitalized patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Cephalosporins; Cross Infection; DNA Primers; Electrophoresis, Gel, Pulsed-Field; Female; Genes, Bacterial; Hematologic Neoplasms; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus epidermidis | 2010 |
Post-cesarean delivery infectious morbidity: Focus on preoperative antibiotics and methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Cesarean Section; Cohort Studies; Cross Infection; Drug Administration Schedule; Female; Humans; Incidence; Infection Control; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Postoperative Complications; Pregnancy; Preoperative Care; Retrospective Studies; Staphylococcal Infections; Surgical Wound Infection; Texas; Treatment Outcome | 2010 |
CTX-M-type fluoroquinolone-resistant Escherichia coli: analysis of the colonization of residents and inanimate surfaces 1 year after a first case of urinary tract infection at a nursing home in France.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nursing Homes; Urinary Tract Infections | 2010 |
Asymptomatic catheter related Rhizobium radiobacter infection in a haploidentical hemapoetic stem cell recipient.
Topics: Agrobacterium tumefaciens; Amikacin; Anti-Bacterial Agents; Blood; Catheter-Related Infections; Catheterization, Central Venous; Catheters; Cefepime; Cephalosporins; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infant; Severe Combined Immunodeficiency; Stem Cell Transplantation | 2010 |
Investigating the impact of the definition of previous antibiotic exposure related to isolation of extended spectrum β-lactamase-producing Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Black or African American; Case-Control Studies; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Female; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Michigan; Middle Aged; Multivariate Analysis; Nursing Homes; Odds Ratio; Renal Dialysis; Retrospective Studies; Risk Factors; United States | 2011 |
No impact of limited cephalosporin use on prevalence of methicillin-resistant Staphylococcus aureus in the intensive care unit.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Humans; Infection Control; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Prevalence; Regression Analysis; Staphylococcal Infections; Time Factors | 2010 |
Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Staphylococcal Infections; Vancomycin Resistance | 2011 |
The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cost Savings; Cross Infection; Drug Costs; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Escherichia; Health Policy; Hospitals; Humans; Imipenem; Klebsiella; Meropenem; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Staphylococcus aureus; Teicoplanin; Thienamycins; Turkey; Vancomycin | 2011 |
Prevalence and characterization of cephalosporin resistance in nonpathogenic Escherichia coli from food-producing animals slaughtered in Poland.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cattle; Cephalosporins; Chickens; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Mutation; Poland; Poultry; Prevalence; Swine; Turkey | 2012 |
Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Databases, Factual; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2011 |
Clinical and electroencephalographic assessment of cefepime during treatment of nosocomial infections in neurological patients.
Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Electroencephalography; Female; Humans; Infusions, Intravenous; Male; Mental Disorders; Microbial Sensitivity Tests; Middle Aged; Pilot Projects; Young Adult | 2011 |
Cefepime-associated thrombocytopenia in a critically ill patient.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Cephalosporins; Critical Illness; Cross Infection; Humans; Intensive Care Units; Male; Middle Aged; Pneumothorax; Rhabdomyolysis; Sepsis; Thrombocytopenia | 2011 |
Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Databases, Factual; Drug Resistance, Multiple, Bacterial; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Hospitals; Humans; Infant; Male; Middle Aged; Morbidity; Prevalence; Spain; Young Adult | 2011 |
Increasing burden of hospital acquired infections: resistance to cephalosporin antibiotics among klebsiella and Escherichia coli.
Topics: Anti-Bacterial Agents; Cephalosporins; Cost of Illness; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; India; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2011 |
Genetic characterization of the mechanisms of resistance to amoxicillin/clavulanate and third-generation cephalosporins in Salmonella enterica from three Spanish hospitals.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Clavulanic Acid; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Salmonella enterica; Salmonella Infections; Spain | 2011 |
Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Cohort Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Proteus mirabilis; Spain; Young Adult | 2012 |
[An algorithm for identification of CTX-M-type beta-lactamase genes using restriction fragment length polymorphism analysis of PCR-product].
Topics: Algorithms; Amplified Fragment Length Polymorphism Analysis; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Genotyping Techniques; Humans; Multigene Family; Polymorphism, Restriction Fragment Length; Reference Standards; Scorpion Venoms | 2011 |
[Frequency of enzymes associated with reduced sensitivity to beta-lactam antibiotics in enterobacteria isolates, Caracas, Venezuela].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Genotype; Hospitals, Urban; Humans; Microbial Sensitivity Tests; Phenotype; Substrate Specificity; Venezuela | 2011 |
Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Hospitals; Humans; Male; Middle Aged; Multivariate Analysis; New Zealand; Retrospective Studies; Risk Factors | 2012 |
Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Humans; Intensive Care Units; Male; Middle Aged; Paris; Prevalence | 2012 |
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Doripenem; Humans; Kidney; Metabolic Clearance Rate; Pneumonia; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic | 2012 |
Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2016 |
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Binding Sites; Carbapenems; Ceftazidime; Cephalosporins; Cross Infection; Gene Expression; Humans; Imipenem; Kinetics; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Protein Binding; Protein Isoforms; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Cross Infection; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Genotype; Hospitals; Humans; Infant; Klebsiella pneumoniae; Male; Middle Aged; Molecular Epidemiology; Retrospective Studies; Risk Factors; Serratia marcescens; Tertiary Healthcare; Young Adult | 2012 |
Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus.
Topics: Advisory Committees; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Europe; General Practice; Humans; Primary Health Care; Secondary Care; Time Factors | 2012 |
Spread of CTX-M-15 positive Providencia spp. causing urinary tract infections at the University Hospital Split in Croatia.
Topics: beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Providencia; R Factors; Urinary Tract Infections | 2012 |
Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2012 |
AmpC β-lactamases in nosocomial isolates of Klebsiella pneumoniae from India.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Humans; India; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam | 2012 |
Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study.
Topics: Adult; Aged; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cohort Studies; Cross Infection; Diarrhea; Female; Ganciclovir; Humans; Male; Middle Aged; Prospective Studies; Transplants | 2012 |
[Group A streptococcal meningitis].
Topics: Amoxicillin; Ampicillin; Cephalosporins; Child, Preschool; Community-Acquired Infections; Cross Infection; Female; Hospitals, University; Humans; Incidence; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Morocco; Postoperative Complications; Streptococcal Infections; Streptococcus pyogenes | 2012 |
Risk factors and clinical analysis for invasive fungal infection in neonatal intensive care unit patients.
Topics: Abdomen; Candidemia; Case-Control Studies; Catheterization, Central Venous; Cephalosporins; Cross Infection; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care, Neonatal; Intubation, Intratracheal; Logistic Models; Meningitis, Fungal; Multivariate Analysis; Neutropenia; Retrospective Studies; Risk Factors; Time Factors; Urinary Tract Infections | 2013 |
Nosocomial outbreak of Serratia marcescens in a neonatal intensive care unit.
Topics: Antibiotic Prophylaxis; Austria; Cefuroxime; Cephalosporins; Cross Infection; Disease Outbreaks; Female; Humans; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Risk Factors; Serratia Infections; Serratia marcescens | 2002 |
First occurrence of transferable extended-spectrum beta-lactamase hydrolyzing cefoperazone in multiresistant nosocomial strains of Klebsiella pneumoniae from two hospitals in Czech and Slovak Republics.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Cross Infection; Czech Republic; Drug Interactions; Drug Resistance, Multiple; Escherichia coli; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Proteus mirabilis; Slovakia | 2002 |
Serratia bacteremia in a large university hospital: trends in antibiotic resistance during 10 years and implications for antibiotic use.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Hospitals, University; Humans; Incidence; Infant; Infant, Newborn; Korea; Length of Stay; Male; Middle Aged; Morbidity; Recurrence; Retrospective Studies; Risk Factors; Serratia Infections; Survival Rate | 2002 |
[Hospital hygiene is important].
Topics: Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Cross Infection; Diarrhea; Disinfection; Enterocolitis, Necrotizing; Germany; Humans; Quality Assurance, Health Care; Sterilization | 2003 |
Cefepime use in a pediatric intensive care unit reduces colonization with resistant bacilli.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Colony Count, Microbial; Cross Infection; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units, Pediatric; Male; Microbial Sensitivity Tests; Sensitivity and Specificity | 2003 |
The effect of an enhanced infection-control policy on the incidence of Clostridium difficile infection and methicillin-resistant Staphyloccocus aureus colonization in acute elderly medical patients.
Topics: Aged; Cephalosporins; Clostridioides difficile; Communicable Disease Control; Cross Infection; Cross-Sectional Studies; Drug Utilization; England; Enterocolitis, Necrotizing; Hand Disinfection; Humans; Methicillin Resistance; Penicillanic Acid; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim | 1998 |
Restriction of third-generation cephalosporin use decreases infection-related mortality.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Cephalosporin Resistance; Cephalosporins; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Risk Factors; Survival Rate | 2003 |
Dynamics of cytokines and role of immunocorrection in nosocomial pneumonia.
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Humans; Interferon-gamma; Interleukins; Middle Aged; Pneumonia; Tumor Necrosis Factor-alpha | 2002 |
[A case-control study on risk factors for nosocomial infection by extended-spectrum beta-lactamases-producing bacteria].
Topics: beta-Lactamases; Case-Control Studies; Cephalosporins; China; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Drug Utilization; Female; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Risk Factors | 2003 |
Determination of the frequency of inadequate antibiotic therapy using calculation of indication failure (IF), cumulative indication failure (CIF), and balanced indication failure (BIF).
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Empiricism; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Treatment Failure | 2003 |
Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.
Topics: Case-Control Studies; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Cerebrovascular Disorders; Citrobacter freundii; Critical Care; Cross Infection; Enterobacteriaceae Infections; Female; Humans; Length of Stay; Male; Middle Aged; Risk Factors | 2003 |
Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia.
Topics: Aged; Bronchoalveolar Lavage; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Cross Infection; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals, University; Humans; Infusions, Intravenous; Intensive Care Units; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Prospective Studies; Respiratory Mucosa | 2003 |
In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therapy.
Topics: Anti-Bacterial Agents; Canada; Cephalosporins; Cross Infection; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Retrospective Studies; United States | 2003 |
Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years.
Topics: Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Enterocolitis, Pseudomembranous; Hospitals, Teaching; Humans; Methicillin Resistance; Patient Care Team; Population Surveillance; Prospective Studies; Staphylococcal Infections | 2003 |
[Acute pyelonephritis: bacteriological data and general course of germ resistance].
Topics: Acute Disease; Bacterial Infections; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Pyelonephritis | 2003 |
Risk factors for Clostridium difficile colonisation and toxin production.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bacteriological Techniques; Cephalosporins; Clostridioides difficile; Comorbidity; Cross Infection; Enterocolitis, Necrotizing; Enterotoxins; Feces; Female; Humans; Male; Risk Factors; Scotland | 2003 |
Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.
Topics: Asia; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Pacific Islands; Penicillins; Phenotype; South Africa | 2003 |
Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Case-Control Studies; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Logistic Models; Male; Middle Aged; Risk Factors; Thienamycins | 2004 |
Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance.
Topics: Anti-Bacterial Agents; Argentina; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Prescriptions; Drug Utilization; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2004 |
Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Lactams; Microbial Sensitivity Tests | 2004 |
Antibiotic-mediated release of tumour necrosis factor alpha and norharman in patients with hospital-acquired pneumonia and septic encephalopathy.
Topics: Adult; Aged; Aged, 80 and over; Brain Diseases; Carbolines; Cephalosporins; Chi-Square Distribution; Cross Infection; Female; Harmine; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia; Prospective Studies; Retrospective Studies; Sepsis; Statistics, Nonparametric; Tumor Necrosis Factor-alpha | 2004 |
Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
Topics: Amino Acid Sequence; beta-Lactamases; beta-Lactams; Blotting, Southern; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cloning, Molecular; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant, Newborn; Intensive Care, Neonatal; Isoelectric Focusing; Japan; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
[3-Year experience of use of cefepime (Maxipime) for the treatment of hospital infections in a specialized surgical hospital].
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Humans; Neoplasms | 2004 |
In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Glycopeptides; Humans; In Vitro Techniques; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Staphylococcus haemolyticus | 2004 |
Antibiotic prescribing policy and Clostridium difficile diarrhoea.
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Injections, Intravenous; Ireland; Male; Practice Patterns, Physicians'; Retrospective Studies | 2004 |
High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns.
Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cephalosporins; Cross Infection; Enterobacter; Enterobacteriaceae Infections; Enzyme Inhibitors; Gene Frequency; Genes, Bacterial; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Mutation | 2004 |
Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporins.
Topics: Cephalosporins; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Feces; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Spain | 2004 |
Bacteria of preoperative urinary tract infections contaminate the surgical fields and develop surgical site infections in urological operations.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Japan; Male; Methicillin Resistance; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Specimen Handling; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Urinary Tract Infections; Urine; Urologic Surgical Procedures | 2004 |
[Fecal colonization by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Feces; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Polymerase Chain Reaction; Prevalence; Retrospective Studies; Spain | 2004 |
In vitro activity of cefepime and cefpirome compared to other third-generation cephem antibiotics against gram-negative nosocomial pathogens.
Topics: Cefepime; Cefpirome; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests | 2004 |
Recurrent Klebsiella pneumoniae mycotic aneurysm in a diabetic patient and emergence of an extended-spectrum beta-lactamase (CTX-M-24)-containing Klebsiella pneumoniae strain after prolonged treatment with first-generation cephalosporins for mycotic aneur
Topics: Aneurysm; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Diabetes Complications; DNA, Bacterial; Drug Resistance, Microbial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged | 2004 |
Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriological Techniques; Bronchoalveolar Lavage Fluid; Cephalosporins; Cross Infection; Early Diagnosis; Female; France; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Population Surveillance; Practice Guidelines as Topic; Prospective Studies; Pseudomonas Infections; Treatment Outcome; Ventilators, Mechanical | 2005 |
[Microbiological diagnostic and antibiotic management of community aquired and nosocomial pneumonias in intensive care units in Germany].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Bronchoalveolar Lavage Fluid; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enzyme Inhibitors; Germany; Guidelines as Topic; Humans; Intensive Care Units; Penicillins; Piperacillin; Pneumonia; Population Surveillance; Respiration, Artificial; Surveys and Questionnaires | 2005 |
[Germs that produce the extended spectrum betalactamases].
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Emergencies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Imipenem; Leukemia; Lymphoma, Non-Hodgkin; Male; Morocco; Neutropenia; Retrospective Studies; Shock, Septic; Time Factors | 2004 |
Investigation of a nosocomial outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Utilization; Electrophoresis, Gel, Pulsed-Field; Escherichia coli Proteins; Female; France; Humans; Infection Control; Intensive Care Units; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Phylogeny; Polymerase Chain Reaction; Risk Factors; Time Factors | 2005 |
Extended Spectrum Beta-Lactamase-producing Klebsiella pneumoniae outbreaks during a third generation cephalosporin restriction policy.
Topics: beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Prescriptions; Drug Resistance, Multiple; Hospitals, University; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2005 |
Fourth-generation cephalosporins: in vitro activity against nosocomial gram-negative bacilli compared with beta-lactam antibiotics and ciprofloxacin.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Hospitals, University; Humans; Klebsiella; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2005 |
Unnoticed spread of integron-carrying Enterobacteriaceae in intensive care units.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gene Transfer, Horizontal; Humans; Integrases; Integrons; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Sequence Analysis, DNA | 2005 |
Outbreak of extended spectrum beta-lactamase-producing Klebsiella pneumoniae infection in a neonatal intensive care unit related to onychomycosis in a health care worker.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Hand; Hand Dermatoses; Health Personnel; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Onychomycosis | 2005 |
CTX-M: changing the face of ESBLs in the UK.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; United Kingdom | 2005 |
Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Taiwan | 2005 |
Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins | 2005 |
[Cox proportional hazards regression analysis].
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Cephalosporins; Confidence Intervals; Cross Infection; Female; Follow-Up Studies; Humans; Male; Middle Aged; Models, Theoretical; Pneumonia; Prognosis; Proportional Hazards Models; Respiration, Artificial; Risk; Risk Factors; Sex Factors; Time Factors | 2005 |
An outbreak of SHV-5 producing Klebsiella pneumoniae in a neonatal intensive care unit; meropenem failed to avoid fecal colonization.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cohort Studies; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Feces; Female; Genes, Bacterial; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Molecular Epidemiology; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Sequence Analysis, DNA; Thienamycins | 2005 |
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Taiwan | 2005 |
Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefdinir; Cephalosporins; Child; Child, Preschool; Colony Count, Microbial; Cross Infection; Female; Humans; Infant; Infusions, Parenteral; Male; Microbial Sensitivity Tests; Retrospective Studies; Urinary Tract Infections; Urine | 2006 |
Prevalence of extended-spectrum beta-lactamases in isolates of the Enterobacter cloacae complex from German hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Genotype; Germany; Hospitals; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA; Sulfonamides | 2006 |
The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants.
Topics: Blood; Candidiasis; Carbapenems; Catheterization, Central Venous; Central Nervous System Fungal Infections; Cephalosporins; Cerebrospinal Fluid; Comorbidity; Cross Infection; Enterocolitis, Necrotizing; Fungemia; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Prospective Studies; Registries; Risk Factors; Superinfection | 2006 |
Effectiveness of cephalosporins in the sputum of patients with nosocomial bronchopneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bronchopneumonia; Cephalosporins; Cross Infection; Electrophoresis, Capillary; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Intubation, Intratracheal; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Sputum; Treatment Outcome | 2006 |
Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2006 |
Risk factors for Clostridium difficile-associated diarrhea on an adult hematology-oncology ward.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Case-Control Studies; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Enterotoxins; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Risk Factors | 2006 |
Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporins; Cohort Studies; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2006 |
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical | 2006 |
Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospita
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli; Greece; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Prospective Studies; Tazobactam; Time Factors | 2007 |
Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains.
Topics: beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Czech Republic; Databases, Factual; Drug Utilization Review; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies | 2007 |
An algorithm to estimate the importance of bacterial acquisition routes in hospital settings.
Topics: Algorithms; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Intensive Care Units; Likelihood Functions; Markov Chains; Netherlands; Sentinel Surveillance | 2007 |
Prevalence and characterization of extended-spectrum cephalosporin-resistant nontyphoidal Salmonella isolates in adults in Saint Petersburg, Russia (2002-2005).
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gastroenteritis; Humans; Microbial Sensitivity Tests; Prevalence; Russia; Salmonella enterica | 2007 |
In vitro activity of cefditoren against clinical isolates of Escherichia coli from a Korean hospital.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Korea; Microbial Sensitivity Tests | 2007 |
Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; China; Cohort Studies; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Logistic Models; Male; Microbial Sensitivity Tests; Multivariate Analysis; Respiration, Artificial; Retrospective Studies; Risk Factors | 2007 |
Community-acquired versus nosocomial Klebsiella pneumonia bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Treatment Outcome | 2007 |
Control of multi-resistant bacteria and ventilator-associated pneumonia: is it possible with changes in antibiotics?
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Prospective Studies; Tazobactam | 2007 |
Antibiotic use in nursing home-acquired pneumonia.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Therapy, Combination; Drug Utilization; Homes for the Aged; Hospital Mortality; Hospitalization; Humans; Injections, Intramuscular; Nursing Homes; Pneumonia, Aspiration; Pneumonia, Bacterial; Survival Rate; Treatment Failure | 2007 |
[Reduced incidence of Staphylococcus isolation in nosocomial setting after introducing preoperative antibiotic prophylaxis guidelines].
Topics: Antibiotic Prophylaxis; Cephalosporins; Cross Infection; Drug Utilization; Guideline Adherence; Humans; Incidence; Italy; Methicillin Resistance; Postoperative Complications; Practice Guidelines as Topic; Preanesthetic Medication; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Surgery Department, Hospital | 2007 |
[Early diagnosis of hospital infection based on monitoring of wound microflora at purulent surgery unit].
Topics: Bacteria; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Early Diagnosis; Humans; Microbial Sensitivity Tests; Suppuration; Surgery Department, Hospital; Wound Infection | 2007 |
[ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections].
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Middle Aged; Risk Factors; Urinary Tract Infections | 2007 |
Methicillin-resistant Staphylococcus aureus carriage in a long-term care facility: hypothesis about selection and transmission.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Carrier State; Catheterization; Cephalosporins; Cross Infection; Diagnostic Imaging; Female; Fluoroquinolones; Homes for the Aged; Humans; Male; Methicillin Resistance; Models, Biological; Prevalence; Staphylococcal Infections; Staphylococcus aureus | 2008 |
In vitro activity of ceftobiprole against clinical isolates of Pseudomonas aeruginosa obtained from Canadian intensive care unit (ICU) patients as part of the CAN-ICU Study.
Topics: Anti-Bacterial Agents; Canada; Cephalosporins; Cross Infection; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
A study of Clostridium difficile-associated disease at King Chulalongkorn Memorial Hospital, Thailand.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Cephalosporins; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals, Public; Humans; Infant; Male; Metronidazole; Middle Aged; Retrospective Studies; Risk Factors; Thailand; Treatment Outcome | 2008 |
Detection and molecular characterisation of plasmidic AmpC beta-lactamases in Klebsiella pneumoniae isolates from a tertiary-care hospital in Dublin, Ireland.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genotype; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Prevalence; Sequence Analysis, DNA | 2008 |
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus | 2008 |
[Current features of antibacterial therapy of nosocomial pneumonia].
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pneumonia, Bacterial; Siberia; Survival Rate; Treatment Outcome | 2008 |
Population pharmacokinetics of cefepime in neonates with severe nosocomial infections.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Female; Gestational Age; Humans; Infant, Newborn; Infusions, Intravenous; Intensive Care Units, Neonatal; Male; Mexico; Models, Biological; Nonlinear Dynamics | 2008 |
Identification of plasmid-encoded extended spectrum beta-lactamases produced by a clinical strain of Proteus mirabilis.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple; Hospitals, Military; Humans; Intensive Care Units; Microbial Sensitivity Tests; Penicillins; Plasmids; Proteus Infections; Proteus mirabilis; Tunisia | 2009 |
[Use of moxalactam in intensive care units: clinical and bacteriological results related to serum and bronchial concentrations ].
Topics: Adult; Aged; Cephalosporins; Cephamycins; Critical Care; Cross Infection; Female; Humans; Male; Middle Aged; Moxalactam; Respiratory Tract Infections; Sepsis; Sputum | 1982 |
Evaluation of cefotaxime in a hospital with high antibiotic resistance rates.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged | 1980 |
[In vitro activity of ceftazidime compared with five beta-lactamase stable compounds against clinical strains of Acinetobacter calcoaceticus ].
Topics: Acinetobacter; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Humans | 1982 |
Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Humans; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1982 |
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Topics: Acinetobacter; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Gentamicins; Imipenem; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia; Thienamycins | 1982 |
[In vitro action of moxalactam on hospital bacteria. Results of a multicenter survey].
Topics: Bacteria; Bacteroides fragilis; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Haemophilus; Humans; Microbial Sensitivity Tests; Moxalactam; Staphylococcus; Streptococcus | 1983 |
[In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
Topics: Anti-Bacterial Agents; Bacteria; Cefmenoxime; Cefotaxime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Moxalactam | 1983 |
[In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
Topics: Bacteria; Cefotaxime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Staphylococcus aureus | 1983 |
Effect of broad-spectrum cephalosporins on the microbial flora of recipients.
Topics: Adult; Aged; Bacterial Infections; Bacteroides; Candidiasis; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Feces; Female; Humans; Male; Middle Aged; Neoplasms; Pharynx; Staphylococcus; Streptococcus | 1983 |
[Clinical use of new cephalosporins for severe infections in internal medicine].
Topics: Bacteroides Infections; Cefotaxime; Cefoxitin; Cephalosporins; Cross Infection; Drug Therapy, Combination; Enterobacteriaceae Infections; Gentamicins; Humans; Pseudomonas Infections; Staphylococcal Infections; Structure-Activity Relationship | 1983 |
Open study of ceftazidime in serious infections due to multiply-resistant bacteria.
Topics: Abscess; Adolescent; Adult; Aged; Bacterial Infections; Bronchopneumonia; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Osteomyelitis; Peritonitis; Sepsis; Urinary Tract Infections; Wound Infection | 1983 |
The activity in vitro of ceftazidime (GR 20263) and moxalactam (LY 127935) against Gram-negative bacteria from hospital patients.
Topics: Bacteria; Ceftazidime; Cephalosporins; Cephamycins; Cross Infection; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
[Antibiotic strategy in nosocomial infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cross Infection; Humans; Penicillin Resistance; Penicillins | 1983 |
Rational antibiotic prophylaxis.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cross Infection; Humans; Infection Control; Penicillins; Postoperative Complications; Premedication; Surgical Wound Infection | 1981 |
[In vitro action of new beta-lactams on hospital strains of Pseudomonas aeruginosa producing beta-lactamases ].
Topics: beta-Lactamases; Cephalosporins; Cross Infection; Humans; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa | 1982 |
[Pseudomonas aeruginosa bacteriaemia: new clinical and therapeutic aspects ].
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Female; Humans; Male; Middle Aged; Penicillins; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis | 1982 |
[3d generation cephalosporins in nosocomial infections].
Topics: Adolescent; Adult; Aged; Azlocillin; Cephalosporins; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Middle Aged; Penicillins; Tobramycin | 1983 |
The prevalence of high-level methicillin resistance in multiply resistant hospital staphylococci.
Topics: Cephalosporins; Cross Infection; Humans; Methicillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus | 1981 |
Antimicrobial therapy for surgical patients.
Topics: Aminoglycosides; Anti-Infective Agents; Cephalosporins; Cross Infection; Humans; Operating Room Nursing; Penicillins; Postoperative Complications; Premedication | 1982 |
Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Cross Infection; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Sepsis | 1982 |
In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Cefotetan; Cephalosporins; Cephamycins; Cross Infection; Humans; Microbial Sensitivity Tests | 1982 |
Nosocomial pneumonia.
Topics: Aminoglycosides; Cephalosporins; Cross Infection; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Penicillin G; Pneumococcal Infections; Pneumonia; Pseudomonas Infections; Staphylococcal Infections | 1981 |
Klebsiella bacteremia.
Topics: Adolescent; Adult; Aged; Aminoglycosides; California; Cephalosporins; Child; Child, Preschool; Cross Infection; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Klebsiella Infections; Male; Middle Aged; Prognosis; Sepsis; Space-Time Clustering | 1980 |
[Medical and therapeutic aspects of hospital infections].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephradine; Cross Infection; Drug Resistance, Microbial; Gentamicins; Humans; Sisomicin | 1980 |
Failure of cefotaxime treatment in a patient with penicillin-resistant pneumococcal meningitis and confirmation of nosocomial spread by random amplified polymorphic DNA analysis.
Topics: Base Sequence; Cefotaxime; Cephalosporins; Cross Infection; DNA Primers; DNA, Bacterial; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant; Meningitis, Pneumococcal; Molecular Sequence Data; Penicillin Resistance; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Streptococcus pneumoniae; Treatment Failure; Vancomycin | 1995 |
Transferable resistance to cefotaxime in nosocomial Klebsiella pneumoniae and Escherichia coli strains due to their production of extended-spectrum beta-lactamase in Slovakia.
Topics: beta-Lactamases; Cefotaxime; Ceftibuten; Cephalosporins; Conjugation, Genetic; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovakia | 1995 |
Antibiotic resistant organisms in a NICU.
Topics: Cefotaxime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal | 1995 |
The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections; Vancomycin | 1995 |
Clostridium difficile colitis: an increasing hospital-acquired illness.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cholestyramine Resin; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Hospital Mortality; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Metronidazole; Middle Aged; Premedication; Retrospective Studies; Surgical Procedures, Operative; Survival Rate; Vancomycin | 1995 |
Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals.
Topics: beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cross Infection; DNA, Bacterial; Greece; Humans; Microbial Sensitivity Tests; Plasmids; Serratia Infections; Serratia marcescens | 1994 |
Enterobacter cloacae in a neonatal intensive care unit: account of an outbreak and its relationship to use of third generation cephalosporins.
Topics: Blood Gas Analysis; Case-Control Studies; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Cross Infection; Disease Outbreaks; Disease Reservoirs; Enterobacter cloacae; Enterobacteriaceae Infections; Equipment Contamination; Humans; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; London | 1994 |
Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.
Topics: beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; International Cooperation; Microbial Sensitivity Tests | 1994 |
Clinical characteristics and outcome of Acinetobacter infections in CAPD patients.
Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Treatment Outcome | 1994 |
The in vitro activity of FCE 22101 against gram-negative aerobic isolates resistant to third generation cephalosporins.
Topics: Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; Humans; Microbial Sensitivity Tests | 1994 |
Extended-spectrum beta-lactamase in Proteus mirabilis.
Topics: Cephalosporinase; Cephalosporins; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Genetic Markers; Humans; Intensive Care Units; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Pancreatitis-Associated Proteins; Plasmids; Proteus Infections; Proteus mirabilis | 1994 |
Clostridium difficile colonization in residents of long-term care facilities: prevalence and risk factors.
Topics: Aged; Aged, 80 and over; Carrier State; Cephalosporins; Clostridioides difficile; Cross Infection; Diabetes Mellitus, Type 2; Diagnosis-Related Groups; Enterocolitis, Pseudomembranous; Environmental Monitoring; Epidemiological Monitoring; Feces; Female; Health Surveys; Histamine H2 Antagonists; Hospitalization; Humans; Infection Control; Logistic Models; Male; Narcotics; Prevalence; Risk Factors; Severity of Illness Index; Skilled Nursing Facilities; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
Nosocomial epiglottitis associated with penicillin- and cephalosporin-resistant Streptococcus pneumoniae bacteremia.
Topics: Bacteremia; Cephalosporins; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Epiglottitis; Humans; Male; Penicillin Resistance; Pneumococcal Infections | 1994 |
Klebsiella pneumoniae meningitis: prognostic factors.
Topics: Adult; Aged; Cephalosporins; Community-Acquired Infections; Cross Infection; Female; Humans; Incidence; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Middle Aged; Prognosis; Taiwan | 1994 |
Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins.
Topics: Case-Control Studies; Cephalosporins; Confidence Intervals; Cross Infection; Diarrhea; Disease Outbreaks; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Feces; Humans; Infection Control; Length of Stay; Logistic Models; Odds Ratio; Risk Factors | 1994 |
In-vitro activity of cefepime against bacterial pathogens from hospitalized patients.
Topics: Cefepime; Cephalosporins; Cross Infection; Humans; Microbial Sensitivity Tests | 1993 |
Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Indicators and Reagents; Microbial Sensitivity Tests | 1993 |
Epidemiology and sensitivity of 8625 ICU and hematology/oncology bacterial isolates in Europe. International Study Group.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Europe; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospital Units; Humans; Intensive Care Units; Microbial Sensitivity Tests; Prevalence | 1993 |
Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Europe; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospital Units; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin; Prevalence | 1993 |
Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study.
Topics: Adult; Aged; Bacteremia; Case-Control Studies; Cephalosporins; Cross Infection; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Risk Factors | 1993 |
Molecular epidemiology and antimicrobial susceptibility testing. Testing of quinolone-resistant Staphylococcus aureus strains isolated in Brazil.
Topics: Bacteriophage Typing; Brazil; Carrier State; Cephalosporins; Cross Infection; Disease Outbreaks; DNA Restriction Enzymes; DNA, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 1993 |
Monotherapy of gram-negative nosocomial pneumonia.
Topics: Adult; Cephalosporins; Cross Infection; Gram-Negative Bacterial Infections; Humans; Male; Pneumonia; Risk Factors; Wounds and Injuries | 1993 |
An audit of ciprofloxacin use in a district general hospital.
Topics: Anti-Infective Agents; Bacterial Infections; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Utilization Review; Hospitals, General; Humans; Ofloxacin; Postoperative Complications; United Kingdom | 1995 |
The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms.
Topics: Adult; beta-Lactamases; Case-Control Studies; Cephalosporins; Citrobacter; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Risk Factors; Serratia marcescens | 1995 |
The choice of antibacterial drugs.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Erythromycin; Gram-Negative Bacteria; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Neutropenia; Penicillins; Pneumonia, Mycoplasma; Pneumonia, Staphylococcal; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 1996 |
Non-O1 Vibrio cholerae bacteremia in patients with cirrhosis: 5-yr experience from a single medical center.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Ceftriaxone; Cephalosporins; Cephalothin; Cross Infection; Culture Media; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Gentamicins; Humans; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Risk Factors; Seafood; Seawater; Vibrio cholerae | 1996 |
Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit.
Topics: Bacterial Typing Techniques; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cloning, Molecular; Cross Infection; Disease Outbreaks; Fatal Outcome; Genes, Bacterial; Humans; Infant; Infant, Newborn; Intensive Care, Neonatal; Isoelectric Focusing; Klebsiella; Klebsiella Infections; Plasmids | 1995 |
[Variation in transfer resistance to cefotaxime, ceftazidime and aztreonam in strains of Acinetobacter sp., Enterobacter sp. and Citrobacter sp. isolated from the same university hospitals].
Topics: Acinetobacter; Aztreonam; Cefotaxime; Ceftazidime; Cephalosporins; Citrobacter; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacter; Hospitals, University; Humans; Monobactams; R Factors | 1996 |
Comparative distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporinase; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Intensive Care Units; Penicillinase; Penicillins; Phenotype; Pseudomonas aeruginosa; Serotyping | 1996 |
Development of Aeromonas hydrophila bacteremia in a patient recovering from cholera.
Topics: Adult; Aeromonas; Bacteremia; Ceftriaxone; Cephalosporins; Cholera; Cross Infection; Drug Resistance, Microbial; Female; Gram-Negative Bacterial Infections; Humans | 1996 |
[Practical use of cefepime in an University hospital. Retrospective study of 35 cases].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Cross Infection; Drug Therapy, Combination; Female; Fluoroquinolones; Glycopeptides; Hospitals, University; Humans; Injections, Intravenous; Lung Diseases; Male; Middle Aged; Neutropenia; Retrospective Studies; Sepsis | 1996 |
Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center.
Topics: Ceftazidime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Veterans; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Ohio; Plasmids | 1996 |
Activity of cefepime against nosocomial blood culture isolates.
Topics: Bacteremia; Bacteria; Cefepime; Cephalosporins; Cross Infection; Humans; Microbial Sensitivity Tests | 1995 |
A hospital outbreak of high-level beta-lactam-resistant Enterobacter spp.: association more with ampicillin and cephalosporin therapy than with nosocomial transmission.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Case-Control Studies; Cephalosporins; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Enterobacter; Enterobacteriaceae Infections; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Polymorphism, Restriction Fragment Length | 1996 |
Effect of replacing cefotaxime with ceftizoxime in a hospital where penicillin-resistant pneumococcal disease is prevalent.
Topics: Adult; Cefotaxime; Ceftizoxime; Cephalosporin Resistance; Cephalosporins; Costs and Cost Analysis; Cross Infection; Female; Humans; Length of Stay; Male; Middle Aged; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 1996 |
Risk factors for mortality associated with enterococcal bloodstream infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Risk Factors; Streptococcal Infections; United States; Vancomycin | 1996 |
Sequential emergence of multi-resistant Klebsiella pneumoniae in Bahrain.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bahrain; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Retrospective Studies; Time Factors | 1995 |
Cefepime activity against Pseudomonas aeruginosa: evaluation of Etest and two disc diffusion methods.
Topics: Cefepime; Ceftazidime; Cephalosporins; Colony Count, Microbial; Cross Infection; Diffusion; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quality Control; Reference Standards; Reproducibility of Results | 1996 |
Activity of third generation cephalosporins against Pseudomonas aeruginosa in high risk hospital units.
Topics: Cephalosporins; Cross Infection; Drug Resistance, Microbial; Hospital Units; Humans; Pseudomonas aeruginosa; Risk Factors | 1996 |
Multiple antibiotic resistance (MAR) index and its reversion in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1997 |
Hydrolysis of imipenem, meropenem, ceftazidime, and cefepime by multiresistant nosocomial strains of Sphingobacterium multivorum.
Topics: Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Hydrolysis; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 1997 |
Hospital-acquired Clostridium difficile diarrhoea.
Topics: Anti-Infective Agents; Cefuroxime; Cephalosporins; Ciprofloxacin; Clostridioides difficile; Cross Infection; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Penicillins; Thoracic Diseases | 1997 |
Clostridium difficile colitis after aortic surgery.
Topics: Aged; Antibiotic Prophylaxis; Aortic Diseases; Cefuroxime; Cephalosporins; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Incidence; Male; Postoperative Complications; Retrospective Studies; Risk Factors | 1997 |
Comparative in vitro activity of cefepime against nosocomial isolates.
Topics: Acinetobacter; beta-Lactamases; Cefepime; Cephalosporins; Cross Infection; Enterobacteriaceae; Greece; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Staphylococcus aureus | 1997 |
Antibiotic resistance. Epidemiology of resistance in intensive therapy units (ITUs).
Topics: 4-Quinolones; Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enzyme Induction; Gram-Negative Bacteria; Gram-Positive Bacterial Infections; Humans; Incidence; Intensive Care Units; Methicillin Resistance; Mutation; Prevalence; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; United Kingdom; Vancomycin | 1997 |
Susceptibilities of Chryseobacterium indologenes and Chryseobacterium meningosepticum to cefepime and cefpirome.
Topics: Cefepime; Cefpirome; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Flavobacterium; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 1997 |
[Analysis of the etiologic structure of urinary tract infection and antibiotic-resistance of its pathogens].
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Urinary Tract Infections | 1997 |
In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sample.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Erythromycin; Humans; Penicillins; Streptococcal Infections; Streptococcus; Vancomycin | 1997 |
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries | 1997 |
Long-term investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases in a university hospital.
Topics: beta-Lactamases; Cephalosporins; Cross Infection; Deoxyribonucleases, Type II Site-Specific; Disease Outbreaks; DNA Fingerprinting; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; France; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Polymorphism, Restriction Fragment Length | 1998 |
Strategies and options for minimizing resistance emergence in pulmonary infections.
Topics: Acinetobacter; Anti-Infective Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Fluoroquinolones; Hospitals; Humans; Lung Diseases; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Respiratory Tract Infections; Scotland; Streptococcus pneumoniae | 1998 |
[Comparative activity of meropenem and other antibiotics against the pathogens of nosocomial infections].
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1998 |
The choice of antibacterial drugs.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporins; Community-Acquired Infections; Costs and Cost Analysis; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Humans; Macrolides; Meningitis, Bacterial; Meningitis, Meningococcal; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Neutropenia; Pneumococcal Infections; Pneumonia, Bacterial; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 1998 |
[Perioperative antibiotic prophylaxis in visceral surgery--pro and contra].
Topics: Antibiotic Prophylaxis; Cephalosporins; Cross Infection; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Metronidazole; Microbial Sensitivity Tests; Surgical Wound Infection; Treatment Outcome | 1997 |
Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase, originating from a contaminated ultrasonography coupling gel.
Topics: Adult; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Contamination; Drug Resistance, Microbial; Equipment Contamination; Female; Gels; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Ultrasonography | 1998 |
The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable.
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Cephalosporins; Colony Count, Microbial; Cross Infection; Drug Resistance, Microbial; Enteral Nutrition; Enterococcus; Female; Humans; Infection Control; Male; Middle Aged; Proportional Hazards Models; Risk; Risk Factors; Vancomycin | 1998 |
Cefpirome: epidemiological survey in intensive care units and hematological units in The Netherlands. The Dutch Study Group.
Topics: Bacterial Infections; Cefpirome; Cephalosporins; Cross Infection; Data Collection; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematology; Hospital Units; Humans; Intensive Care Units; Microbial Sensitivity Tests; Netherlands; Species Specificity | 1998 |
Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.
Topics: Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cefoxitin; Cephalosporins; Cephamycins; Cross Infection; Disease Outbreaks; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Spain | 1998 |
Meropenem monotherapy as empiric treatment of nosocomial lower respiratory tract infection.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Critical Illness; Cross Infection; Drug Therapy, Combination; Humans; Meropenem; Pneumonia, Bacterial; Severity of Illness Index; Thienamycins; Tobramycin; Treatment Outcome | 1998 |
Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; beta-Lactamases; Cefepime; Cephalosporins; Cross Infection; Humans; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Pseudomonas aeruginosa; Pseudomonas Infections; Turkey | 1998 |
Inducible beta-lactam resistance in Aeromonas hydrophila: therapeutic challenge for antimicrobial therapy.
Topics: Aeromonas hydrophila; Bacteremia; Base Sequence; beta-Lactamases; Burns; Cephalosporin Resistance; Cephalosporins; Cross Infection; DNA Primers; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Gram-Negative Bacterial Infections; Humans; Middle Aged; Mutation; Polymerase Chain Reaction; Surgical Wound Infection | 1998 |
In-vitro activities of cefepime and other beta-lactam antibiotics against clinical isolates from a Colombian teaching hospital.
Topics: Anti-Bacterial Agents; Bacteria; Cefepime; Cephalosporins; Colombia; Cross Infection; Hospitals, Teaching; Humans | 1998 |
Control of an outbreak of a highly beta-lactam-resistant Enterobacter cloacae strain in a neonatal special care unit.
Topics: Ampicillin; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Penicillin G; Penicillins; Sweden | 1998 |
Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene.
Topics: beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Child; Cross Infection; DNA Fingerprinting; Genes, Bacterial; Hospitals, Pediatric; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Poland; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length | 1998 |
Utility of serial rectal swab cultures for detection of ceftazidime- and imipenem-resistant gram-negative bacilli from patients in the intensive care unit.
Topics: Adult; Aged; beta-Lactam Resistance; Ceftazidime; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rectum; Thienamycins | 1998 |
Diversification of Escherichia coli expressing an SHV-type extended-spectrum beta-lactamase (ESBL) during a hospital outbreak: emergence of an ESBL-hyperproducing strain resistant to expanded-spectrum cephalosporins.
Topics: beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cross Infection; Disease Outbreaks; Escherichia coli; Escherichia coli Infections; Gene Dosage; Humans; Microbial Sensitivity Tests; Phenotype; Poland | 1999 |
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Homes for the Aged; Humans; Klebsiella; Klebsiella Infections; Male; Multivariate Analysis; Nursing Homes; Plasmids | 1999 |
Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome.
Topics: Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Female; Hospitals, Teaching; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Taiwan | 1999 |
An assessment of the hidden and total antibiotic costs of four parenteral cephalosporins.
Topics: Cephalosporins; Cross Infection; Drug Compounding; Drug Costs; Humans | 1995 |
Novel antibiotics excel for hospital infections and offer long action.
Topics: Anti-Bacterial Agents; Cefamandole; Cephalosporins; Cephamycins; Cross Infection; Humans; United States | 1982 |
Empiric therapy of infected patients in critical care units.
Topics: Cephalosporins; Cross Infection; Humans; Infections; Intensive Care Units; Pharmacy and Therapeutics Committee; Pneumonia; United States | 1986 |
Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients.
Topics: Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Case-Control Studies; Ceftazidime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple; Female; Hand Disinfection; Humans; Intensive Care Units; Intubation, Intratracheal; Male; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Risk Factors | 1999 |
Emergence of multidrug-resistant Enterobacter cloacae: nosocomial outbreak or change of microbial ecology?
Topics: Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Retrospective Studies | 1999 |
Nosocomial meningitis in children after ventriculoperitoneal shunt insertion.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Postoperative Complications; Retrospective Studies; Risk Factors; Vancomycin; Ventriculoperitoneal Shunt | 1999 |
New methods of control against postoperative methicillin-resistant Staphylococcus aureus infection.
Topics: Cephalosporins; Cross Infection; Digestive System Surgical Procedures; Humans; Incidence; Infection Control; Japan; Methicillin Resistance; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus | 1999 |
Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: therapeutic considerations and outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria, Anaerobic; Cefotaxime; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Prevotella; Retrospective Studies; Treatment Outcome | 1999 |
Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Imipenem; Infection Control; Intensive Care Units; Paris | 1999 |
An antibiotic policy associated with reduced risk of Clostridium difficile-associated diarrhoea.
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Cost Control; Cross Infection; Drug Utilization; Enterocolitis, Pseudomembranous; Humans; Injections; Risk Factors; United Kingdom | 1999 |
[The comparative activity of cefepime and other current antibiotics against microorganisms isolated from patients in pediatric intensive therapy units].
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cross Infection; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units, Pediatric; Microbial Sensitivity Tests | 1999 |
Comparison of the activity of two broad-spectrum cephalosporins tested against 2,299 strains of Pseudomonas aeruginosa isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
Topics: Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cross Infection; Databases, Factual; Humans; Microbial Sensitivity Tests; North America; Pseudomonas aeruginosa | 2000 |
In-vitro activity of FK 037 (Cefoselis), a novel 4(th) generation cephalosporin, compared to cefepime and cefpirome on nosocomial staphylococci and gram-negative isolates.
Topics: Acinetobacter; Cefepime; Cefpirome; Ceftizoxime; Cephalosporins; Cross Infection; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus aureus; Stenotrophomonas | 2000 |
Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei.
Topics: Amino Acid Sequence; Aztreonam; Bacterial Proteins; Base Sequence; beta-Lactamases; Cefepime; Cefotaxime; Cefoxitin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Cloning, Molecular; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; France; Hafnia; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Plasmids; Polymerase Chain Reaction | 2000 |
Clostridium difficile-associated diarrhoea in hospitalised patients.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Cephalosporins; Clostridioides difficile; Costs and Cost Analysis; Cross Infection; Diarrhea; Drug Costs; Enterocolitis, Pseudomembranous; Female; Humans; Incidence; Length of Stay; Male; Middle Aged; Nursing Homes; Retrospective Studies; Risk Factors | 2000 |
Diversity of beta-lactam resistance levels among related Klebsiella pneumoniae strains isolated in an intensive care unit.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Ceftazidime; Cephalosporins; Clavulanic Acid; Cross Infection; Disease Outbreaks; Drug Therapy, Combination; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2000 |
Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
Topics: Adolescent; Adult; Aeromonas; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Lactams; Male; Middle Aged; Prognosis; Risk Factors | 2000 |
Cefpirome and continuous venovenous hemofiltration.
Topics: Cefpirome; Cephalosporins; Cross Infection; Hemofiltration; Humans | 2000 |
Feedback is necessary in strategies to reduce hospital acquired infection.
Topics: Cephalosporins; Clostridium Infections; Communication; Cross Infection; Cross-Over Studies; Diarrhea; Humans; Medical Audit | 2000 |
Control of glycopeptide-resistant enterococci in an oncology unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fever; Glycopeptides; Humans; Infection Control; Neoplasms; Neutropenia; Oncology Service, Hospital; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome | 2000 |
When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia.
Topics: Amphotericin B; Analysis of Variance; Anti-Bacterial Agents; Antifungal Agents; Bacteremia; Candida; Candida albicans; Candidiasis; Catheterization, Central Venous; Cephalosporins; Cross Infection; Diagnosis, Differential; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Logistic Models; Retrospective Studies; Risk Factors; Staphylococcal Infections | 2000 |
Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit.
Topics: Burn Units; Cephalosporins; Clinical Protocols; Cross Infection; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin; Vancomycin Resistance; Wounds and Injuries | 2000 |
Treatment guideline for nursing home-acquired pneumonia.
Topics: Aged; Ceftriaxone; Cephalosporins; Cross Infection; Drug Therapy, Combination; Frail Elderly; Humans; Injections, Subcutaneous; Nursing Homes; Pneumonia; Practice Guidelines as Topic | 2000 |
[Some problems of the current therapy of infective endocarditis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Echocardiography; Endocarditis, Bacterial; Follow-Up Studies; Gentamicins; Humans; Male; Oxacillin; Plasmapheresis; Recurrence; Time Factors | 2000 |
Locally delivered antibodies combined with systemic antibiotics confer synergistic protection against antibiotic-resistant burn wound infection.
Topics: Animals; Burns; Ceftazidime; Cephalosporins; Combined Modality Therapy; Cross Infection; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Synergism; Female; Immunoglobulins, Intravenous; Infusions, Intravenous; Injections, Subcutaneous; Mice; Mice, Inbred Strains; Pseudomonas Infections; Survival Analysis; Wound Infection | 2000 |
Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacteria; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillins; Regression Analysis; Sulbactam; Superinfection; Survival Analysis | 2001 |
[Nosocomial enterobacter - sepsis in neonatal intensive care unit in Pleven].
Topics: Bulgaria; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Humans; Hygiene; Incidence; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Pregnancy; Retrospective Studies; Sepsis; Workforce | 2000 |
Antimicrobial use and susceptibility rates in isolates from intensive care unit and other nosocomial inpatient and outpatient areas.
Topics: Ambulatory Care Facilities; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Cross Infection; Disease Susceptibility; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Humans; Intensive Care Units; Monobactams; Prevalence; Pseudomonas aeruginosa; Staphylococcus aureus | 2001 |
Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins.
Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae | 2000 |
Staphylococcus aureus bacteriuria and surgical site infections by methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Bacteriuria; Cephalosporins; Cross Infection; Humans; Methicillin Resistance; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Urinary Tract | 2001 |
Case-control study of risk factors for the development of enterococcal bacteremia.
Topics: Adult; Aged; Bacteremia; Case-Control Studies; Catheters, Indwelling; Cephalosporins; Cross Infection; Enterococcus; Female; Humans; Imipenem; Incidence; Male; Middle Aged; Multivariate Analysis; Neutropenia; Prospective Studies; Risk Factors; Statistics, Nonparametric; Thienamycins | 2001 |
[Activity of cefepime compared with other antibiotics against major hospital bacterial pathogens].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests | 2001 |
Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.
Topics: beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Intensive Care Units; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2001 |
Epidemiology of ceftazidime-resistant Klebsiella pneumoniae in a large university hospital in Tel Aviv.
Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Chi-Square Distribution; Cross Infection; Drug Resistance, Microbial; Hospitals, University; Hospitals, Urban; Humans; Incidence; Intensive Care Units; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Probability; Risk Factors | 2000 |
Antibiotics for community-acquired pneumonia: time to return to the straight and narrow?
Topics: Adult; Australia; beta-Lactam Resistance; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans; Penicillins; Pneumonia | 2001 |
Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.
Topics: Adult; Amikacin; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Ribotyping | 2001 |
[Antibiotic therapy in Italy. Current data and proposals for the future].
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Therapy, Combination; Humans; Intensive Care Units; Italy | 2001 |
Prevalence of ceftriaxone- and ceftazidime-resistant gram-negative bacteria in long-term-care facilities.
Topics: Ceftazidime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nursing Homes; United States; United States Department of Veterans Affairs | 2001 |
Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins.
Topics: Analysis of Variance; Bacterial Infections; Brazil; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Infant, Newborn; Infection Control; Inservice Training; Intensive Care Units, Neonatal; Prospective Studies; Risk | 2001 |
[Cefotaxime, twenty years later. Observational study in critically ill patients].
Topics: Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Utilization; Humans; Intensive Care Units; Prospective Studies; Spain | 2001 |
Efficacy of cefepime versus ceftazidime in the treatment of adult pneumonia.
Topics: Adult; Aged; Cefepime; Ceftazidime; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial | 2001 |
Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.
Topics: Ceftazidime; Cephalosporins; Critical Care; Cross Infection; Drug Incompatibility; Drug Stability; Drug Therapy, Combination; Humans; Infusions, Intravenous; Midazolam; Nicardipine; Pneumonia, Bacterial; Propofol; Temperature; Vancomycin | 2001 |
Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Internal Medicine; Logistic Models | 2001 |
Carriage of Staphylococcus aureus and of gram-negative bacilli resistant to third-generation cephalosporins in cirrhotic patients: a prospective assessment of hospital-acquired infections.
Topics: Adult; Aged; Carrier State; Cephalosporin Resistance; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; France; Hospital Units; Humans; Liver Cirrhosis; Male; Middle Aged; Nasal Cavity; Prevalence; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Urine | 2001 |
Widespread resistance to new antimicrobials in a university hospital before clinical use.
Topics: Acinetobacter; Bacteria; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Singapore | 2001 |
Factors associated with nosocomial diarrhea and Clostridium difficile-associated disease on the adult wards of an urban tertiary care hospital.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Case-Control Studies; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Enteral Nutrition; Enterocolitis, Pseudomembranous; Feces; Female; Food, Fortified; Hospitals, Urban; Humans; Male; Middle Aged; Prospective Studies; Risk Factors | 2000 |
Is it reasonable to use third generation cephalosporins to treat animals?
Topics: Animals; Cephalosporin Resistance; Cephalosporins; Cross Infection; Gram-Negative Bacterial Infections; Hospitals, Animal; Humans; Microbial Sensitivity Tests; Zoonoses | 2001 |
Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital.
Topics: Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Prescriptions; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Taiwan | 2002 |
Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-pectrum beta-lactamase in Pseudomonas aeruginosa in Thailand.
Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Frequency; Humans; Integrases; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Thailand; Transduction, Genetic | 2002 |
Eradication of endotracheal tube biofilm by nebulised gentamicin.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biofilms; Cefotaxime; Cefuroxime; Cephalosporins; Cross Infection; Female; Gentamicins; Humans; Infusions, Parenteral; Intubation, Intratracheal; Male; Middle Aged; Pneumonia, Bacterial; Statistics, Nonparametric | 2002 |
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carrier State; Case-Control Studies; Cefepime; Cephalosporins; Cross Infection; Drug Therapy, Combination; Drug Utilization Review; Escherichia coli Infections; Feces; Female; Formularies, Hospital as Topic; Gentamicins; Hospitals, Community; Hospitals, Urban; Humans; Infection Control; Klebsiella Infections; Length of Stay; Male; Middle Aged; Pennsylvania; Prevalence; Risk Factors; Sulbactam | 2002 |
Ceftriaxone and cefotaxime use in Victorian hospitals.
Topics: Bacterial Infections; Cefotaxime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Utilization Review; Guideline Adherence; Hospitals; Hospitals, Teaching; Humans; Logistic Models; Practice Guidelines as Topic; Victoria | 2002 |
[The patient with bacterial infection in the hospital. Report from the 1st International TV-Satellite Conference, Germany, Austria, Switzerland, U.S.A. on 27 February 1978].
Topics: Austria; Bacterial Infections; Cephalosporins; Cephamycins; Congresses as Topic; Cross Infection; Germany, West; Switzerland; Telecommunications; United States | 1978 |
Klebsiella cross-infection with capsular serotypes 68 and 21.
Topics: Aged; Cefoxitin; Cephalosporins; Cross Infection; Drug Evaluation; Drug Resistance, Microbial; England; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; London; Male; Urinary Tract Infections | 1979 |
[Problems of antibiotic therapy].
Topics: Cefoxitin; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Escherichia coli Infections; Humans; Intensive Care Units; Urinary Tract Infections | 1978 |
Antibiotics in trauma.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Carbenicillin; Cephalosporins; Cross Infection; Drug Combinations; Drug Hypersensitivity; Humans; Infection Control; Infections; Penicillin G; Penicillins; Wounds and Injuries | 1977 |
Hospital antibiotic policy in a health district.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Economics, Hospital; Enterobacteriaceae; Hospitals; Humans | 1979 |
Use of antimicrobial drugs in general hospitals: patterns of prophylaxis.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Utilization; Hospitals, General; Humans; Length of Stay; Penicillin G; Pennsylvania; Surgical Procedures, Operative; Tetracyclines; Time Factors; Utilization Review | 1979 |
The problems, diagnosis and treatment of infection by Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Cross Infection; Erythromycin; Fusidic Acid; Humans; Penicillin Resistance; Penicillins; Staphylococcal Infections; Sulfonamides | 1979 |
[Therapy of bacterial penumonias and their complications with and without pathogen isolation].
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Hypersensitivity; Empyema; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Lung Abscess; Lung Diseases, Fungal; Penicillin Resistance; Penicillins; Pleural Diseases; Pneumococcal Infections; Pneumonia; Pneumonia, Staphylococcal; Streptococcal Infections | 1975 |
[Kefzol in prophylactic treatment of orthopedic patients. Retrospective study with ampicillin].
Topics: Ampicillin; Bacterial Infections; Cefazolin; Cephalosporins; Cross Infection; Drug Evaluation; Humans; Orthopedics; Surgical Wound Infection | 1976 |
[Gentamicin in orthopedic surgery].
Topics: Administration, Topical; Ampicillin; Bone and Bones; Bone Cements; Carbenicillin; Cephalosporins; Colistin; Cross Infection; Drug Therapy, Combination; Gentamicins; Humans; Orthopedics; Penicillins; Surgical Wound Infection; Wound Infection | 1975 |
Antimicrobial resistance: patterns and trends in the National University Hospital, Singapore (1989-1991).
Topics: Cephalosporins; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Hospitals, University; Humans; Klebsiella; Microbial Sensitivity Tests; Penicillin Resistance; Prevalence; Singapore; Staphylococcus aureus | 1992 |
[Managements of hospital MRSA infections in digestive tract surgery].
Topics: Cephalosporins; Cross Infection; Digestive System Surgical Procedures; Humans; Methicillin Resistance; Postoperative Complications; Premedication; Staphylococcal Infections; Staphylococcus aureus | 1992 |
[Evolution of the bacteria responsible for surgical infection. n 8-year study in our department].
Topics: Amikacin; Ampicillin Resistance; Bacteria; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Penicillin Resistance; Surgical Procedures, Operative; Time Factors | 1992 |
[1st Spanish epidemic of plasmid resistance to 3d generation cephalosporins: the implication of SHV-2].
Topics: Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Incidence; Microbial Sensitivity Tests; R Factors; Spain; Species Specificity | 1992 |
[Outbreak of a nosocomial infection of SHV2-beta-lactamase-containing Klebsiella pneumonia strains in an operative intensive care unit].
Topics: beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Germany; Humans; Intensive Care Units; Klebsiella pneumoniae; Microbial Sensitivity Tests | 1992 |
[Cephalosporins--a common cause of nosocomial Clostridium difficile diarrhea].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Retrospective Studies; Sweden | 1992 |
The incidence and beta-lactam resistance of Proteus vulgaris in hospital infections: the last decade.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Aztreonam; Bacteremia; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Phenotype; Proteus Infections; Proteus vulgaris; Spain; Urinary Tract Infections | 1991 |
[Diagnosis and therapy of pneumonia caused by gram-negative bacillus including legionella].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Haemophilus Infections; Humans; Klebsiella Infections; Legionnaires' Disease; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections | 1991 |
[The Norrköping study. Cephalosporins are often the implicating factors in Clostridium difficile infections].
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Clostridioides difficile; Colitis; Cross Infection; Diarrhea; Drug Utilization; Humans; Middle Aged; Retrospective Studies; Sweden | 1991 |
The influence of clinical use of antibiotics and the sensitivity of strains isolated from postoperative infections--a comparison of nosocomial pathogens with strains isolated from the bacterial flora of patients.
Topics: Bacteria; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Postoperative Complications; Pseudomonas aeruginosa; Serotyping; Staphylococcus aureus | 1991 |
Clostridium difficile disease in a department of surgery. The significance of prophylactic antibiotics.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Diagnosis, Differential; Disease Outbreaks; Enterocolitis, Pseudomembranous; Female; Hospitals, University; Humans; Incidence; Male; Middle Aged; Quebec; Surgery Department, Hospital | 1991 |
The changing ecology of hospital bacteria and the selective role of cephalosporins.
Topics: Bacteria; Bacterial Infections; Cefamandole; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Western Australia | 1991 |
Risk factors for Clostridium difficile cytotoxin-positive diarrhea after control for horizontal transmission.
Topics: Bacterial Proteins; Bacterial Toxins; Case-Control Studies; Causality; Cephalosporins; Clindamycin; Clostridioides difficile; Cross Infection; Diarrhea; Female; Hospitalization; Humans; Middle Aged; Risk Factors | 1991 |
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin | 1990 |
Patterns and mechanisms of beta-lactam resistance among isolates of Escherichia coli from hospitals in the United States.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Chromosomes, Bacterial; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Nucleic Acid Hybridization; Plasmids | 1990 |
[Analysis of methicillin-cephem resistant Staphylococcus aureus (MRSA) hospital infection and toxigenicity of MRSA].
Topics: Bacterial Toxins; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterotoxins; Humans; Methicillin Resistance; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Surgery Department, Hospital | 1990 |
[Activity of cefpirome against bacteria isolated from hospitalized patients].
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests | 1989 |
Comparative in vitro activity of cefepime (BMY 28142) against multiresistant nosocomial isolates of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1989 |
Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital.
Topics: Cephalosporins; Clostridium Infections; Cross Infection; Drug Utilization; Feces; Fluorescent Antibody Technique; Hospitals, General; Humans; Microbial Sensitivity Tests; Risk Management | 1989 |
[Experiences of postoperative staphylococcal enteritis caused by methicillin-cephem resistant Staphylococcus aureus (MRSA) and the state of the isolation of MRSA].
Topics: Adult; Aged; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enteritis; Humans; Male; Methicillin; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 1989 |
Treatment of nosocomial pneumonia: monotherapy versus combination therapy.
Topics: Aged; Cephalosporins; Clindamycin; Costs and Cost Analysis; Cross Infection; Drug Therapy, Combination; Gentamicins; Humans; Middle Aged; Pneumonia | 1989 |
Cephalosporins as risk factor for enterococcal nosocomial urinary tract infections.
Topics: Cephalosporins; Cross Infection; Humans; Risk; Streptococcal Infections; Urinary Tract Infections | 1986 |
Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.
Topics: Amikacin; beta-Lactamases; Cefotaxime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Paris; Recurrence; Urinary Tract Infections | 1987 |
Prior antimicrobial therapy and resistance of Enterobacter Citrobacter and Serratia to third generation cephalosporins.
Topics: Cephalosporins; Citrobacter; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Serratia marcescens | 1988 |
[3d generation cephalosporins: effect on polyresistant hospital bacteria in vitro].
Topics: Bacteria; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans | 1987 |
Transferable resistance to cephalosporins, ureidopenicillins and trimethoprim.
Topics: Azlocillin; Cephalosporins; Cross Infection; Humans; Penicillin Resistance; R Factors; Trimethoprim | 1986 |
Enterobacter cloacae bacteremia: clinical analysis of 41 cases.
Topics: Adult; Cephalosporins; Cross Infection; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Sepsis | 1988 |
Nosocomial enterococcal infections: association with use of third-generation cephalosporin antibiotics.
Topics: Aged; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Female; Hospital Bed Capacity, 100 to 299; Hospitals, Community; Humans; Male; New York; Risk Factors; Streptococcal Infections; Urinary Tract Infections | 1988 |
Bacteremia complicating acute leukemia with special reference to its incidence and changing etiological patterns.
Topics: Acute Disease; Adolescent; Adult; Aged; Bacteria; Cephalosporins; Child; Cross Infection; Female; Humans; Leukemia; Male; Middle Aged; Sepsis; Serotyping | 1988 |
[Cephalosporins in pediatrics].
Topics: Adult; Bacterial Infections; Cephalosporins; Child; Cross Infection; Drug Tolerance; Humans | 1987 |
In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients.
Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Ciprofloxacin; Cross Infection; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Quinolines; Thienamycins | 1986 |
Nosocomial and nursing home-acquired pneumonia. Recent therapeutic advances.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Cilastatin; Clavulanic Acid; Clavulanic Acids; Cross Infection; Cyclopropanes; Humans; Imipenem; Nursing Homes; Pneumonia; Thienamycins; Ticarcillin | 1987 |
[Comparison of the in vitro activity of several cephalosporins on Staphylococcus aureus strains isolated in hospitals of northern Chile].
Topics: beta-Lactamases; Cephalosporins; Chile; Cross Infection; Drug Resistance, Microbial; In Vitro Techniques; Microbial Sensitivity Tests; Staphylococcus aureus | 1986 |
Urinary pathogens and bacterial sensitivity in hospitalized urological patients based upon clinical aspects.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cephalosporins; Cross Infection; Drug Combinations; Female; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Penicillins; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
[Sensitivity to aminoglycosides and cephalosporins of staphylococci and gram-negative bacteria isolated from patients hospitalized in Wrocław clinics (1985)].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Staphylococcus | 1987 |
A perspective of cephalosporins in pneumonia.
Topics: Cephalosporins; Costs and Cost Analysis; Cross Infection; Drug Resistance, Microbial; Humans; Immune Tolerance; Kinetics; Pneumonia; Pneumonia, Aspiration; Structure-Activity Relationship | 1987 |
Comparative in vitro evaluation of BMY-28142, a new broad-spectrum cephalosporin, versus other beta-lactams against multiresistant gram-negative isolates.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 1987 |
Staphylococcal infections in hospital.
Topics: Catheters, Indwelling; Cephalosporins; Cross Infection; Gentamicins; Humans; Methicillin; Penicillin Resistance; Penicillins; Peritoneal Dialysis, Continuous Ambulatory; Prostheses and Implants; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; United Kingdom; Vancomycin | 1986 |
Comparison of nosocomial infections due to Staphylococcus aureus and enterococci in a general hospital.
Topics: Adult; Aged; Cephalosporins; Cross Infection; Female; Hospitals, General; Humans; Male; Middle Aged; Opportunistic Infections; Respiratory Tract Infections; Risk Factors; Staphylococcal Infections; Streptococcal Infections; Surgical Wound Infection | 1987 |
Have the new beta-lactams rendered the aminoglycosides obsolete for the treatment of serious nosocomial infections?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Hearing; Humans; Kidney | 1986 |
[In vitro sensitivity of hospital-isolated pathogenic bacterial strains to 4 different cephalosporins: cephaloridine, cefotaxime, cefoxitin, cefonicid].
Topics: Bacteria; Cefamandole; Cefonicid; Cefotaxime; Cefoxitin; Cephaloridine; Cephalosporins; Cross Infection; Humans; Microbial Sensitivity Tests | 1986 |
Antimicrobial activity, bacterial resistance, and antimicrobial pharmacology. Is it possible to use new agents cost-effectively?
Topics: Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Cross Infection; Drug Resistance, Microbial; Humans; Kinetics | 1985 |
Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis | 1985 |
Third generation cephalosporins--a panacea for intensive care patients?
Topics: Bacterial Infections; Cephalosporins; Cross Infection; Humans; Intensive Care Units; Moxalactam | 1985 |
Impact of injectable cephalosporins on the gastrointestinal microflora: observations in healthy volunteers and hospitalized patients.
Topics: Bacteria; Bile; Cefotaxime; Cephalosporins; Cross Infection; Digestive System; Hospitalization; Humans; Injections | 1985 |
The use of new broad spectrum antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Critical Care; Cross Infection; Drug Utilization; Humans | 1985 |
Antibiotic-resistant streptococci in the mouths of children treated with penicillin.
Topics: Ampicillin; Cephalosporins; Child; Child, Preschool; Cross Infection; Humans; Mouth; Penicillin Resistance; Penicillins; Saliva; Streptococcus | 1967 |
Growing clinical significance of methcillin-resistant Staphylococcus aureus.
Topics: Cephalosporins; Cross Infection; Humans; Methicillin; Oxacillin; Penicillin Resistance; Penicillins; Staphylococcal Infections; Staphylococcus; Vancomycin | 1968 |
[Methicillin resistant staphylococci. Bacteriology, clinical picture and epidemiology].
Topics: Cephalosporins; Cross Infection; Humans; Methicillin; Oxacillin; Penicillin Resistance; Penicillins; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Staphylococcus Phages; Surgical Wound Infection; Switzerland; Urinary Tract Infections | 1968 |
Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.
Topics: Boston; Cephalosporins; Cross Infection; Culture Media; Drug Resistance, Microbial; Enterobacteriaceae Infections; Feces; Female; Gentamicins; Hospitals, General; Humans; Infant; Infant, Newborn; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Pigmentation; Polymyxins; Respiratory Tract Infections; Serotyping; Serratia marcescens; Species Specificity; Sputum; Urinary Tract Infections; Urine; Wounds and Injuries | 1970 |
[Prevention of infectious complications of acute leukemias: place of general and intestinal antibiotic therapy].
Topics: Administration, Oral; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Humans; Infection Control; Infections; Leukemia; Nystatin; Sepsis | 1973 |
[Postoperative wound infections in orthopedic surgery (author's transl)].
Topics: Ampicillin; Antisepsis; Cephalosporins; Cross Infection; Humans; Methods; Orthopedics; Oxacillin; Patient Isolators; Wound Infection | 1974 |
Antibiotic sensitivity of isolates from nosocomial and community-acquired urinary tract infections.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Cephalosporins; Computers; Cross Infection; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Nitrofurantoin; Penicillin Resistance; Urinary Tract Infections | 1973 |
Generalised gram-negative bacillary infections.
Topics: Ampicillin; Bacillus; Bacterial Infections; Bacteriological Techniques; Carbenicillin; Cephalosporins; Cross Infection; Humans; Penicillins; Sepsis | 1972 |
[Compared sensitivities to cephalothin cephaloridine cephalexin and ampicillin of 500 bacterial strains isolated in a hospital].
Topics: Ampicillin; Bacteria; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Cross Infection; Humans; Microbial Sensitivity Tests; Penicillin Resistance | 1972 |
[Clinical incidence of heterogenous resistance of Staphylococcus to penicillin and cephalosporin].
Topics: Cephalosporins; Cross Infection; Female; Humans; Methicillin; Oxacillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus | 1967 |
Methicillin-resistant staphylococcemia: bacteriological failure of treatment with cephalosporins.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Cephalosporins; Cross Infection; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus | 1970 |
Penicillin and related antibiotics: gram-negative infections: urine.
Topics: Ampicillin; Bacillus; Bacteriuria; Cephalosporins; Cross Infection; Cystitis; Humans; Kidney Diseases; Penicillin G; Penicillins; Proteus; Urinary Bladder Diseases; Urinary Tract Infections | 1972 |
The use and abuse of antibiotics--1967.
Topics: Adult; Aged; Anti-Bacterial Agents; Bone Marrow Diseases; Cephalosporins; Cephalothin; Child; Chloramphenicol; Cloxacillin; Cross Infection; Drug Hypersensitivity; Female; Hearing Disorders; Humans; Kanamycin; Male; Methicillin; Middle Aged; Nafcillin; Oxacillin; Penicillin Resistance; Penicillins; Staphylococcal Infections; Wound Infection | 1967 |
Proteus infections in a general hospital. I. Biochemical characteristics and antibiotic susceptibility of the organisms. With special reference to proticine typing and the Dienes phenomenon.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteriocins; Bacteriophage Typing; Carbenicillin; Cephalosporins; Cross Infection; Gentamicins; Humans; Indoles; Kanamycin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Proteus; Proteus Infections | 1971 |
Staphylococcal infections in nurseries.
Topics: Ampicillin; Bacitracin; Cephalosporins; Chloramphenicol; Cross Infection; Erythromycin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Methicillin; Novobiocin; Penicillin G; Sepsis; Tetracycline; Troleandomycin; Vancomycin | 1966 |
Use of cephalosporins in the treatment of Gram-negative bacillary bacteremia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cross Infection; Female; Humans; Infant; Male; Middle Aged; Sepsis | 1971 |
Hospital staphylococci and the new penicillins.
Topics: Cephalosporins; Cephalothin; Cloxacillin; Cross Infection; In Vitro Techniques; Methicillin; Nafcillin; Penicillin Resistance; Penicillins; Staphylococcus; Virulence | 1965 |